Form 10-Q
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
x |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended June 30, 2014
or
¨ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
|
|
For the transition period from
to |
|
|
Commission File Number: 001-14965
The Goldman Sachs Group, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware |
|
13-4019460 |
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
|
|
200 West Street, New York, N.Y. |
|
10282 |
(Address of principal executive offices) |
|
(Zip Code) |
(212) 902-1000
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or
15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
x Yes ¨ No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any,
every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to
submit and post such files).
x Yes
¨ No
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2
of the Exchange Act.
|
|
|
Large accelerated filer x
Accelerated filer ¨ |
|
Non-accelerated filer ¨ (Do not check if a smaller reporting
company) Smaller reporting company ¨ |
Indicate by check mark whether the registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act).
¨ Yes
x No
APPLICABLE ONLY TO CORPORATE ISSUERS
As of July 25, 2014, there were 440,579,936 shares of the registrants common stock outstanding.
THE GOLDMAN SACHS GROUP, INC.
QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2014
INDEX
|
|
|
|
|
Form 10-Q Item Number |
|
Page No. |
|
PART I |
|
FINANCIAL INFORMATION |
|
2 |
|
Item 1 |
|
Financial Statements (Unaudited) |
|
2 |
|
|
|
Condensed Consolidated Statements of Earnings for the three and six months ended June 30,
2014 and June 30, 2013 |
|
2 |
|
|
|
Condensed Consolidated Statements of Comprehensive Income for the three and six months ended June
30, 2014 and June 30, 2013 |
|
3 |
|
|
|
Condensed Consolidated Statements of Financial Condition as of June 30, 2014 and December
31, 2013 |
|
4 |
|
|
|
Condensed Consolidated Statements of Changes in Shareholders Equity for the six months ended June 30, 2014
and year ended December 31, 2013 |
|
5 |
|
|
|
Condensed Consolidated Statements of Cash Flows for the six months ended June 30,
2014 and June 30, 2013 |
|
6 |
|
|
|
Notes to Condensed Consolidated Financial Statements |
|
7 |
|
|
|
Note 1. Description of Business |
|
7 |
|
|
|
Note 2. Basis of Presentation |
|
7 |
|
|
|
Note 3. Significant Accounting
Policies |
|
8 |
|
|
|
Note 4.
Financial Instruments Owned, at Fair Value and Financial Instruments Sold, But Not
Yet Purchased, at Fair Value |
|
13 |
|
|
|
Note 5. Fair Value Measurements |
|
14 |
|
|
|
Note 6. Cash Instruments |
|
16 |
|
|
|
Note 7. Derivatives and Hedging
Activities |
|
27 |
|
|
|
Note 8. Fair Value Option |
|
43 |
|
|
|
Note 9. Collateralized Agreements and
Financings |
|
52 |
|
|
|
Note 10. Securitization Activities |
|
57 |
|
|
|
Note 11. Variable Interest Entities |
|
59 |
|
|
|
Note 12. Other Assets |
|
64 |
|
|
|
Note 13. Goodwill and Identifiable Intangible
Assets |
|
65 |
|
|
|
Note 14. Deposits |
|
66 |
|
|
|
Note 15. Short-Term Borrowings |
|
67 |
|
|
|
Note 16. Long-Term Borrowings |
|
68 |
|
|
|
Note 17. Other Liabilities and Accrued
Expenses |
|
70 |
|
|
|
Note 18. Commitments, Contingencies and
Guarantees |
|
71 |
|
|
|
Note 19. Shareholders Equity |
|
77 |
|
|
|
Note 20. Regulation and Capital Adequacy |
|
79 |
|
|
|
Note 21. Earnings Per Common Share |
|
88 |
|
|
|
Note 22. Transactions with Affiliated Funds |
|
88 |
|
|
|
Note 23. Interest Income and Interest
Expense |
|
89 |
|
|
|
Note 24. Income Taxes |
|
90 |
|
|
|
Note 25. Business Segments |
|
91 |
|
|
|
Note 26. Credit Concentrations |
|
93 |
|
|
|
Note 27. Legal Proceedings |
|
94 |
|
|
|
Report of Independent Registered Public Accounting Firm |
|
101 |
|
|
|
Statistical Disclosures |
|
102 |
|
Item 2 |
|
Managements Discussion and Analysis of Financial Condition and Results of
Operations |
|
104 |
|
Item 3 |
|
Quantitative and Qualitative Disclosures About Market Risk |
|
180 |
|
Item 4 |
|
Controls and Procedures |
|
180 |
|
PART II |
|
OTHER INFORMATION |
|
180 |
|
Item 1 |
|
Legal Proceedings |
|
180 |
|
Item 2 |
|
Unregistered Sales of Equity Securities and Use of Proceeds |
|
180 |
|
Item 6 |
|
Exhibits |
|
181 |
|
SIGNATURES |
|
182 |
|
|
|
|
|
|
|
Goldman Sachs June 2014 Form 10-Q |
|
1 |
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)
THE GOLDMAN
SACHS GROUP, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Earnings
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended June |
|
|
|
|
Six Months
Ended June |
|
in millions, except per share amounts |
|
|
2014 |
|
|
|
2013 |
|
|
|
|
|
2014 |
|
|
|
2013 |
|
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment banking |
|
|
$1,781 |
|
|
|
$1,552 |
|
|
|
|
|
$ 3,560 |
|
|
|
$ 3,120 |
|
|
|
Investment management |
|
|
1,378 |
|
|
|
1,267 |
|
|
|
|
|
2,876 |
|
|
|
2,517 |
|
|
|
Commissions and fees |
|
|
786 |
|
|
|
873 |
|
|
|
|
|
1,658 |
|
|
|
1,702 |
|
|
|
Market making |
|
|
2,185 |
|
|
|
2,692 |
|
|
|
|
|
4,824 |
|
|
|
6,129 |
|
|
|
Other principal transactions |
|
|
1,995 |
|
|
|
1,402 |
|
|
|
|
|
3,498 |
|
|
|
3,483 |
|
Total non-interest revenues |
|
|
8,125 |
|
|
|
7,786 |
|
|
|
|
|
16,416 |
|
|
|
16,951 |
|
|
|
Interest income |
|
|
2,579 |
|
|
|
2,663 |
|
|
|
|
|
5,173 |
|
|
|
5,271 |
|
|
|
Interest expense |
|
|
1,579 |
|
|
|
1,837 |
|
|
|
|
|
3,136 |
|
|
|
3,520 |
|
Net interest income |
|
|
1,000 |
|
|
|
826 |
|
|
|
|
|
2,037 |
|
|
|
1,751 |
|
Net revenues, including net interest income |
|
|
9,125 |
|
|
|
8,612 |
|
|
|
|
|
18,453 |
|
|
|
18,702 |
|
Operating
expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation and benefits |
|
|
3,924 |
|
|
|
3,703 |
|
|
|
|
|
7,935 |
|
|
|
8,042 |
|
|
|
Brokerage, clearing, exchange and
distribution fees |
|
|
613 |
|
|
|
613 |
|
|
|
|
|
1,208 |
|
|
|
1,174 |
|
|
|
Market development |
|
|
141 |
|
|
|
140 |
|
|
|
|
|
279 |
|
|
|
281 |
|
|
|
Communications and technology |
|
|
186 |
|
|
|
182 |
|
|
|
|
|
386 |
|
|
|
370 |
|
|
|
Depreciation and amortization |
|
|
294 |
|
|
|
266 |
|
|
|
|
|
684 |
|
|
|
568 |
|
|
|
Occupancy |
|
|
205 |
|
|
|
210 |
|
|
|
|
|
415 |
|
|
|
428 |
|
|
|
Professional fees |
|
|
224 |
|
|
|
218 |
|
|
|
|
|
436 |
|
|
|
464 |
|
|
|
Insurance reserves |
|
|
|
|
|
|
49 |
|
|
|
|
|
|
|
|
|
176 |
|
|
|
Other expenses |
|
|
717 |
|
|
|
586 |
|
|
|
|
|
1,268 |
|
|
|
1,181 |
|
Total non-compensation expenses |
|
|
2,380 |
|
|
|
2,264 |
|
|
|
|
|
4,676 |
|
|
|
4,642 |
|
Total operating expenses |
|
|
6,304 |
|
|
|
5,967 |
|
|
|
|
|
12,611 |
|
|
|
12,684 |
|
Pre-tax earnings |
|
|
2,821 |
|
|
|
2,645 |
|
|
|
|
|
5,842 |
|
|
|
6,018 |
|
|
|
Provision for taxes |
|
|
784 |
|
|
|
714 |
|
|
|
|
|
1,772 |
|
|
|
1,827 |
|
Net earnings |
|
|
2,037 |
|
|
|
1,931 |
|
|
|
|
|
4,070 |
|
|
|
4,191 |
|
|
|
Preferred stock dividends |
|
|
84 |
|
|
|
70 |
|
|
|
|
|
168 |
|
|
|
142 |
|
Net earnings applicable to common shareholders |
|
|
$1,953 |
|
|
|
$1,861 |
|
|
|
|
|
$ 3,902 |
|
|
|
$ 4,049 |
|
Earnings per common
share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
$ 4.21 |
|
|
|
$ 3.92 |
|
|
|
|
|
$ 8.36 |
|
|
|
$ 8.45 |
|
|
|
Diluted |
|
|
4.10 |
|
|
|
3.70 |
|
|
|
|
|
8.13 |
|
|
|
7.99 |
|
|
|
Dividends declared per common
share |
|
|
$ 0.55 |
|
|
|
$ 0.50 |
|
|
|
|
|
$ 1.10 |
|
|
|
$ 1.00 |
|
|
|
Average common shares
outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
461.7 |
|
|
|
473.2 |
|
|
|
|
|
465.1 |
|
|
|
477.5 |
|
|
|
Diluted |
|
|
475.9 |
|
|
|
503.5 |
|
|
|
|
|
480.1 |
|
|
|
506.6 |
|
The accompanying notes are an integral part of these
condensed consolidated financial statements.
|
|
|
|
|
2 |
|
Goldman Sachs June 2014 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Comprehensive Income
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended June |
|
|
|
|
Six Months
Ended June |
|
in millions |
|
|
2014 |
|
|
|
2013 |
|
|
|
|
|
2014 |
|
|
|
2013 |
|
Net earnings |
|
|
$2,037 |
|
|
|
$1,931 |
|
|
|
|
|
$4,070 |
|
|
|
$4,191 |
|
|
|
Other comprehensive income/(loss) adjustments, net of tax: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Currency translation |
|
|
(30 |
) |
|
|
(30 |
) |
|
|
|
|
(59 |
) |
|
|
(56 |
) |
|
|
Pension and postretirement liabilities |
|
|
(6 |
) |
|
|
(3 |
) |
|
|
|
|
(14 |
) |
|
|
(7 |
) |
|
|
Available-for-sale securities |
|
|
|
|
|
|
(342 |
) |
|
|
|
|
|
|
|
|
(327 |
) |
|
|
Cash flow hedges |
|
|
1 |
|
|
|
|
|
|
|
|
|
2 |
|
|
|
|
|
Other comprehensive loss |
|
|
(35 |
) |
|
|
(375 |
) |
|
|
|
|
(71 |
) |
|
|
(390 |
) |
Comprehensive income |
|
|
$2,002 |
|
|
|
$1,556 |
|
|
|
|
|
$3,999 |
|
|
|
$3,801 |
|
The accompanying notes are an integral part of these condensed consolidated
financial statements.
|
|
|
|
|
|
|
Goldman Sachs June 2014 Form 10-Q |
|
3 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Financial Condition
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
As of |
|
in millions, except share and per share amounts |
|
|
June
2014 |
|
|
|
December 2013 |
|
Assets |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
|
$ 56,983 |
|
|
|
$ 61,133 |
|
|
|
Cash and securities segregated for regulatory and other purposes (includes $23,947 and $31,937 at fair value as of June 2014 and
December 2013, respectively) |
|
|
40,668 |
|
|
|
49,671 |
|
|
|
Collateralized agreements: |
|
|
|
|
|
|
|
|
Securities purchased under agreements to resell and federal funds sold (includes $108,504 and $161,297 at fair value as of June 2014
and December 2013, respectively) |
|
|
109,103 |
|
|
|
161,732 |
|
|
|
Securities borrowed (includes $51,971 and $60,384 at fair value as of June 2014 and December 2013, respectively) |
|
|
164,719 |
|
|
|
164,566 |
|
|
|
Receivables from: |
|
|
|
|
|
|
|
|
Brokers, dealers and clearing organizations |
|
|
28,233 |
|
|
|
23,840 |
|
|
|
Customers and counterparties (includes $7,010 and $7,416 at fair value as of June 2014 and
December 2013, respectively) |
|
|
91,011 |
|
|
|
88,935 |
|
|
|
Financial instruments owned, at fair value (includes $72,244 and $62,348 pledged as collateral as of June 2014 and
December 2013, respectively) |
|
|
345,806 |
|
|
|
339,121 |
|
|
|
Other assets (includes $18 at fair value as of December 2013) |
|
|
23,391 |
|
|
|
22,509 |
|
Total assets |
|
|
$859,914 |
|
|
|
$911,507 |
|
Liabilities and
shareholders equity |
|
|
|
|
|
|
|
|
Deposits (includes $10,134 and $7,255 at fair value as of June 2014 and December 2013, respectively) |
|
|
$ 73,750 |
|
|
|
$ 70,807 |
|
|
|
Collateralized financings: |
|
|
|
|
|
|
|
|
Securities sold under agreements to repurchase, at fair value |
|
|
106,966 |
|
|
|
164,782 |
|
|
|
Securities loaned (includes $1,529 and $973 at fair value as of June 2014 and December 2013, respectively) |
|
|
9,440 |
|
|
|
18,745 |
|
|
|
Other secured financings (includes $23,846 and $23,591 at fair value as of June 2014 and December 2013,
respectively) |
|
|
25,178 |
|
|
|
24,814 |
|
|
|
Payables to: |
|
|
|
|
|
|
|
|
Brokers, dealers and clearing organizations |
|
|
12,263 |
|
|
|
5,349 |
|
|
|
Customers and counterparties |
|
|
199,253 |
|
|
|
199,416 |
|
|
|
Financial instruments sold, but not yet purchased, at fair value |
|
|
124,162 |
|
|
|
127,426 |
|
|
|
Unsecured short-term borrowings, including the current portion of unsecured long-term borrowings (includes $17,617 and $19,067 at fair
value as of June 2014 and December 2013, respectively) |
|
|
45,755 |
|
|
|
44,692 |
|
|
|
Unsecured long-term borrowings (includes $14,703 and $11,691 at fair value as of June 2014 and
December 2013, respectively) |
|
|
167,019 |
|
|
|
160,965 |
|
|
|
Other liabilities and accrued expenses (includes $488 and $388 at fair value as of June 2014
and December 2013, respectively) |
|
|
14,499 |
|
|
|
16,044 |
|
Total liabilities |
|
|
778,285 |
|
|
|
833,040 |
|
|
|
Commitments, contingencies and
guarantees |
|
|
|
|
|
|
|
|
Shareholders
equity |
|
|
|
|
|
|
|
|
Preferred stock, par value $0.01 per share; aggregate liquidation preference of $9,200 and $7,200 as of June 2014 and
December 2013, respectively |
|
|
9,200 |
|
|
|
7,200 |
|
|
|
Common stock, par value $0.01 per share; 4,000,000,000 shares authorized, 849,565,423 and 837,219,068 shares issued as of June 2014
and December 2013, respectively, and 440,734,836 and 446,359,012 shares outstanding as of June 2014 and December 2013, respectively |
|
|
8 |
|
|
|
8 |
|
|
|
Restricted stock units and employee stock options |
|
|
3,709 |
|
|
|
3,839 |
|
|
|
Nonvoting common stock, par value $0.01 per share; 200,000,000 shares authorized, no shares issued and outstanding |
|
|
|
|
|
|
|
|
|
|
Additional paid-in capital |
|
|
49,942 |
|
|
|
48,998 |
|
|
|
Retained earnings |
|
|
75,340 |
|
|
|
71,961 |
|
|
|
Accumulated other comprehensive loss |
|
|
(595 |
) |
|
|
(524 |
) |
|
|
Stock held in treasury, at cost, par value $0.01 per share; 408,830,589 and 390,860,058 shares as
of June 2014 and December 2013, respectively |
|
|
(55,975 |
) |
|
|
(53,015 |
) |
Total shareholders equity |
|
|
81,629 |
|
|
|
78,467 |
|
Total liabilities and shareholders equity |
|
|
$859,914 |
|
|
|
$911,507 |
|
The accompanying notes are an integral part of these condensed consolidated financial statements.
|
|
|
|
|
4 |
|
Goldman Sachs June 2014 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Changes in Shareholders Equity
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended |
|
|
|
|
Year Ended |
|
in millions |
|
|
June
2014 |
|
|
|
|
|
December 2013 |
|
Preferred stock |
|
|
|
|
|
|
|
|
|
|
Balance, beginning of year |
|
|
$ 7,200 |
|
|
|
|
|
$ 6,200 |
|
|
|
Issued |
|
|
2,000 |
|
|
|
|
|
1,000 |
|
Balance, end of period |
|
|
9,200 |
|
|
|
|
|
7,200 |
|
|
|
Common stock |
|
|
|
|
|
|
|
|
|
|
Balance, beginning of year |
|
|
8 |
|
|
|
|
|
8 |
|
|
|
Issued |
|
|
|
|
|
|
|
|
|
|
Balance, end of period |
|
|
8 |
|
|
|
|
|
8 |
|
|
|
Restricted stock units and employee stock options |
|
|
|
|
|
|
|
|
|
|
Balance, beginning of year |
|
|
3,839 |
|
|
|
|
|
3,298 |
|
|
|
Issuance and amortization of restricted stock units and employee stock options |
|
|
1,734 |
|
|
|
|
|
2,017 |
|
|
|
Delivery of common stock underlying restricted stock units |
|
|
(1,633 |
) |
|
|
|
|
(1,378 |
) |
|
|
Forfeiture of restricted stock units and employee stock options |
|
|
(32 |
) |
|
|
|
|
(79 |
) |
|
|
Exercise of employee stock options |
|
|
(199 |
) |
|
|
|
|
(19 |
) |
Balance, end of period |
|
|
3,709 |
|
|
|
|
|
3,839 |
|
|
|
Additional paid-in capital |
|
|
|
|
|
|
|
|
|
|
Balance, beginning of year |
|
|
48,998 |
|
|
|
|
|
48,030 |
|
|
|
Delivery of common stock underlying share-based awards |
|
|
1,919 |
|
|
|
|
|
1,483 |
|
|
|
Cancellation of restricted stock units and employee stock options in satisfaction of withholding tax requirements |
|
|
(1,503 |
) |
|
|
|
|
(599 |
) |
|
|
Preferred stock issuance costs |
|
|
(20 |
) |
|
|
|
|
(9 |
) |
|
|
Excess net tax benefit related to share-based awards |
|
|
549 |
|
|
|
|
|
94 |
|
|
|
Cash settlement of share-based compensation |
|
|
(1 |
) |
|
|
|
|
(1 |
) |
Balance, end of period |
|
|
49,942 |
|
|
|
|
|
48,998 |
|
|
|
Retained earnings |
|
|
|
|
|
|
|
|
|
|
Balance, beginning of year |
|
|
71,961 |
|
|
|
|
|
65,223 |
|
|
|
Net earnings |
|
|
4,070 |
|
|
|
|
|
8,040 |
|
|
|
Dividends and dividend equivalents declared on common stock and restricted stock units |
|
|
(523 |
) |
|
|
|
|
(988 |
) |
|
|
Dividends declared on preferred stock |
|
|
(168 |
) |
|
|
|
|
(314 |
) |
Balance, end of period |
|
|
75,340 |
|
|
|
|
|
71,961 |
|
|
|
Accumulated other comprehensive loss |
|
|
|
|
|
|
|
|
|
|
Balance, beginning of year |
|
|
(524 |
) |
|
|
|
|
(193 |
) |
|
|
Other comprehensive loss |
|
|
(71 |
) |
|
|
|
|
(331 |
) |
Balance, end of period |
|
|
(595 |
) |
|
|
|
|
(524 |
) |
|
|
Stock held in treasury, at cost |
|
|
|
|
|
|
|
|
|
|
Balance, beginning of year |
|
|
(53,015 |
) |
|
|
|
|
(46,850 |
) |
|
|
Repurchased |
|
|
(2,969 |
) |
|
|
|
|
(6,175 |
) |
|
|
Reissued |
|
|
40 |
|
|
|
|
|
40 |
|
|
|
Other |
|
|
(31 |
) |
|
|
|
|
(30 |
) |
Balance, end of period |
|
|
(55,975 |
) |
|
|
|
|
(53,015 |
) |
Total shareholders equity |
|
|
$ 81,629 |
|
|
|
|
|
$ 78,467 |
|
The accompanying notes are an integral part of these
condensed consolidated financial statements.
|
|
|
|
|
|
|
Goldman Sachs June 2014 Form 10-Q |
|
5 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
Six Months
Ended June |
|
in millions |
|
|
2014 |
|
|
|
2013 |
|
Cash flows from operating activities |
|
|
|
|
|
|
|
|
Net earnings |
|
|
$ 4,070 |
|
|
|
$ 4,191 |
|
|
|
Adjustments to reconcile net earnings to net cash provided by/(used for) operating activities |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
684 |
|
|
|
568 |
|
|
|
Share-based compensation |
|
|
1,775 |
|
|
|
1,669 |
|
|
|
Changes in operating assets and liabilities |
|
|
|
|
|
|
|
|
Cash and securities segregated for regulatory and other purposes |
|
|
9,003 |
|
|
|
(2,399 |
) |
|
|
Receivables and payables, net |
|
|
6,772 |
|
|
|
10,066 |
|
|
|
Collateralized transactions (excluding other secured financings), net |
|
|
(14,645 |
) |
|
|
(56,114 |
) |
|
|
Financial instruments owned, at fair value |
|
|
(4,531 |
) |
|
|
36,071 |
|
|
|
Financial instruments sold, but not yet purchased, at fair value |
|
|
(3,279 |
) |
|
|
18,792 |
|
|
|
Other, net |
|
|
(3,541 |
) |
|
|
(7,210 |
) |
Net cash provided by/(used for) operating activities |
|
|
(3,692 |
) |
|
|
5,634 |
|
|
|
Cash flows from investing activities |
|
|
|
|
|
|
|
|
Purchase of property, leasehold improvements and equipment |
|
|
(353 |
) |
|
|
(329 |
) |
|
|
Proceeds from sales of property, leasehold improvements and equipment |
|
|
10 |
|
|
|
33 |
|
|
|
Business acquisitions, net of cash acquired |
|
|
(449 |
) |
|
|
(446 |
) |
|
|
Proceeds from sales of investments |
|
|
469 |
|
|
|
1,521 |
|
|
|
Purchase of available-for-sale securities |
|
|
|
|
|
|
(738 |
) |
|
|
Proceeds from sales of available-for-sale securities |
|
|
|
|
|
|
817 |
|
|
|
Loans held for investment, net |
|
|
(6,490 |
) |
|
|
(2,518 |
) |
Net cash used for investing activities |
|
|
(6,813 |
) |
|
|
(1,660 |
) |
|
|
Cash flows from financing activities |
|
|
|
|
|
|
|
|
Unsecured short-term borrowings, net |
|
|
1,077 |
|
|
|
622 |
|
|
|
Other secured financings (short-term), net |
|
|
1,141 |
|
|
|
(3,764 |
) |
|
|
Proceeds from issuance of other secured financings (long-term) |
|
|
3,413 |
|
|
|
2,641 |
|
|
|
Repayment of other secured financings (long-term), including the current portion |
|
|
(4,840 |
) |
|
|
(1,466 |
) |
|
|
Proceeds from issuance of unsecured long-term borrowings |
|
|
19,804 |
|
|
|
18,502 |
|
|
|
Repayment of unsecured long-term borrowings, including the current portion |
|
|
(15,320 |
) |
|
|
(18,152 |
) |
|
|
Purchase of trust preferred securities |
|
|
(1,362 |
) |
|
|
|
|
|
|
Derivative contracts with a financing element, net |
|
|
574 |
|
|
|
761 |
|
|
|
Deposits, net |
|
|
2,943 |
|
|
|
(729 |
) |
|
|
Common stock repurchased |
|
|
(2,969 |
) |
|
|
(3,125 |
) |
|
|
Dividends and dividend equivalents paid on common stock, preferred stock and restricted stock units |
|
|
(691 |
) |
|
|
(631 |
) |
|
|
Proceeds from issuance of preferred stock, net of issuance costs |
|
|
1,980 |
|
|
|
991 |
|
|
|
Proceeds from issuance of common stock, including stock option exercises |
|
|
56 |
|
|
|
34 |
|
|
|
Excess tax benefit related to share-based compensation |
|
|
550 |
|
|
|
71 |
|
|
|
Cash settlement of share-based compensation |
|
|
(1 |
) |
|
|
|
|
Net cash provided by/(used for) financing activities |
|
|
6,355 |
|
|
|
(4,245 |
) |
Net decrease in cash and cash equivalents |
|
|
(4,150 |
) |
|
|
(271 |
) |
|
|
Cash and cash equivalents, beginning of year |
|
|
61,133 |
|
|
|
72,669 |
|
Cash and cash equivalents, end of period |
|
|
$ 56,983 |
|
|
|
$ 72,398 |
|
SUPPLEMENTAL DISCLOSURES:
Cash payments for interest, net of capitalized interest, were $3.26 billion and $3.33 billion during the six months ended June 2014 and June 2013, respectively.
Cash payments for income taxes, net of refunds, were $2.06 billion and $2.61 billion during the six months ended June 2014 and
June 2013, respectively.
Non-cash activities:
The firm exchanged $175 million of senior guaranteed trust securities held by the firm for $175 million of the firms junior subordinated debt securities held by the issuing trust during the six
months ended June 2014. As a result of this exchange, these senior guaranteed trust securities and junior subordinated debt securities were extinguished.
The accompanying notes are an integral part of these condensed consolidated financial statements.
|
|
|
|
|
6 |
|
Goldman Sachs June 2014 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note 1.
Description of Business
The Goldman Sachs Group, Inc. (Group Inc.), a Delaware
corporation, together with its consolidated subsidiaries (collectively, the firm), is a leading global investment banking, securities and investment management firm that provides a wide range of financial services to a substantial and diversified
client base that includes corporations, financial institutions, governments and high-net-worth individuals. Founded in 1869, the firm is headquartered in New York and maintains offices in all major financial centers around the world.
The firm reports its activities in the following four business segments:
Investment Banking
The firm
provides a broad range of investment banking services to a diverse group of corporations, financial institutions, investment funds and governments. Services include strategic advisory assignments with respect to mergers and acquisitions,
divestitures, corporate defense activities, risk management, restructurings and spin-offs, and debt and equity underwriting of public offerings and private placements, including domestic and cross-border transactions, as well as derivative
transactions directly related to these activities.
Institutional Client Services
The firm facilitates client transactions and makes markets in fixed income, equity, currency and commodity products, primarily with
institutional clients such as corporations, financial institutions, investment funds and governments. The firm also makes markets in and clears client transactions on major stock, options and futures exchanges worldwide and provides financing,
securities lending and other prime brokerage services to institutional clients.
Investing & Lending
The firm invests in and originates loans to provide financing to clients. These investments and loans are typically longer-term in nature.
The firm makes investments, some of which are consolidated, directly and indirectly through funds that the firm manages, in debt securities and loans, public and private equity securities and real estate entities.
Investment Management
The firm provides investment management services and offers investment products (primarily through separately managed accounts and commingled vehicles, such as mutual funds and private investment funds)
across all major asset classes to a diverse set of institutional and individual clients. The firm also offers wealth advisory services, including portfolio management and financial counseling, and brokerage and other transaction services to
high-net-worth individuals and families.
Note 2.
Basis of Presentation
These condensed consolidated financial statements are prepared
in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and include the accounts of Group Inc. and all other entities in which the firm has a controlling financial interest. Intercompany transactions and balances
have been eliminated.
These condensed consolidated financial statements are unaudited and should be read in conjunction
with the audited consolidated financial statements included in the firms Annual Report on Form 10-K for the year ended December 31, 2013. References to the 2013 Form 10-K are to the firms Annual Report on
Form 10-K for the year ended December 31, 2013. The condensed consolidated financial information as of December 31, 2013 has been derived from audited consolidated financial statements not included herein.
These unaudited condensed consolidated financial statements reflect all adjustments that are, in the opinion of management, necessary for
a fair statement of the results for the interim periods presented. These adjustments are of a normal, recurring nature. Interim period operating results may not be indicative of the operating results for a full year.
All references to June 2014, March 2014, December 2013 and June 2013 refer to the firms periods ended, or the
dates, as the context requires, June 30, 2014, March 31, 2014, December 31, 2013 and June 30, 2013, respectively. Any reference to a future year refers to a year ending on December 31 of that year.
Certain reclassifications have been made to previously reported amounts to conform to the current presentation.
|
|
|
|
|
|
|
Goldman Sachs June 2014 Form 10-Q |
|
7 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note 3.
Significant Accounting Policies
The firms significant accounting policies include when and how to measure the fair
value of assets and liabilities, accounting for goodwill and identifiable intangible assets, and when to consolidate an entity. See Notes 5 through 8 for policies on fair value measurements, Note 13 for policies on goodwill and
identifiable intangible assets, and below and Note 11 for policies on consolidation accounting. All other significant accounting policies are either discussed below or included in the following footnotes:
|
|
|
|
|
|
|
Financial Instruments Owned, at Fair Value
and Financial Instruments Sold, But Not Yet
Purchased, at Fair Value |
|
|
Note 4 |
|
|
|
Fair Value Measurements |
|
|
Note 5 |
|
|
|
Cash Instruments |
|
|
Note 6 |
|
|
|
Derivatives and Hedging Activities |
|
|
Note 7 |
|
|
|
Fair Value Option |
|
|
Note 8 |
|
|
|
Collateralized Agreements and Financings |
|
|
Note 9 |
|
|
|
Securitization Activities |
|
|
Note 10 |
|
|
|
Variable Interest Entities |
|
|
Note 11 |
|
|
|
Other Assets |
|
|
Note 12 |
|
|
|
Goodwill and Identifiable Intangible Assets |
|
|
Note 13 |
|
|
|
Deposits |
|
|
Note 14 |
|
|
|
Short-Term Borrowings |
|
|
Note 15 |
|
|
|
Long-Term Borrowings |
|
|
Note 16 |
|
|
|
Other Liabilities and Accrued Expenses |
|
|
Note 17 |
|
|
|
Commitments, Contingencies and Guarantees |
|
|
Note 18 |
|
|
|
Shareholders Equity |
|
|
Note 19 |
|
|
|
Regulation and Capital Adequacy |
|
|
Note 20 |
|
|
|
Earnings Per Common Share |
|
|
Note 21 |
|
|
|
Transactions with Affiliated Funds |
|
|
Note 22 |
|
|
|
Interest Income and Interest Expense |
|
|
Note 23 |
|
|
|
Income Taxes |
|
|
Note 24 |
|
|
|
Business Segments |
|
|
Note 25 |
|
|
|
Credit Concentrations |
|
|
Note 26 |
|
|
|
Legal Proceedings |
|
|
Note 27 |
|
Consolidation
The firm consolidates entities in which the firm has a controlling financial interest. The firm determines whether it has a controlling financial interest in an entity by first evaluating whether the
entity is a voting interest entity or a variable interest entity (VIE).
Voting Interest Entities.
Voting interest entities are entities in which (i) the total equity investment at risk is sufficient to enable the entity to finance its activities independently and (ii) the equity holders have the power to direct the activities of the
entity that most significantly impact its economic performance, the obligation to absorb the losses of the entity and the right to receive the residual returns of the entity. The usual condition for a controlling financial interest in a voting
interest entity is ownership of a majority voting interest. If the firm has a majority voting interest in a voting interest entity, the entity is consolidated.
Variable Interest Entities. A VIE is an entity that lacks one or more of the
characteristics of a voting interest entity. The firm has a controlling financial interest in a VIE when the firm has a variable interest or interests that provide it with (i) the power to direct the activities of the VIE that most
significantly impact the VIEs economic performance and (ii) the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. See Note 11 for further
information about VIEs.
Equity-Method Investments. When the firm does not have a controlling financial interest in an entity but can exert significant influence over the entitys operating and financial policies, the investment is accounted for
either (i) under the equity method of accounting or (ii) at fair value by electing the fair value option available under U.S. GAAP. Significant influence generally exists when the firm owns 20% to 50% of the entitys common stock or
in-substance common stock.
In general, the firm accounts for investments acquired after the fair value option became
available, at fair value. In certain cases, the firm applies the equity method of accounting to new investments that are strategic in nature or closely related to the firms principal business activities, when the firm has a significant degree
of involvement in the cash flows or operations of the investee or when cost-benefit considerations are less significant. See Note 12 for further information about equity-method investments.
|
|
|
|
|
8 |
|
Goldman Sachs June 2014 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Investment Funds. The firm has formed numerous investment funds with third-party investors. These funds are typically organized as limited partnerships or limited liability companies for which the firm acts as general
partner or manager. Generally, the firm does not hold a majority of the economic interests in these funds. These funds are usually voting interest entities and generally are not consolidated because third-party investors typically have rights to
terminate the funds or to remove the firm as general partner or manager. Investments in these funds are included in Financial instruments owned, at fair value. See Notes 6, 18 and 22 for further information about investments in
funds.
Use of Estimates
Preparation of these condensed consolidated financial statements requires management to make certain estimates and assumptions, the most
important of which relate to fair value measurements, accounting for goodwill and identifiable intangible assets, discretionary compensation accruals and the provisions for losses that may arise from litigation, regulatory proceedings and tax
audits. These estimates and assumptions are based on the best available information but actual results could be materially different.
Revenue
Recognition
Financial Assets and Financial Liabilities at Fair
Value. Financial instruments owned, at fair value and Financial instruments sold, but not yet purchased, at fair value are recorded at fair value either under the fair value option or in
accordance with other U.S. GAAP. In addition, the firm has elected to account for certain of its other financial assets and financial liabilities at fair value by electing the fair value option. The fair value of a financial instrument is the amount
that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices.
Fair value measurements do not include transaction costs. Fair value gains or losses are generally included in Market making for positions in Institutional Client Services and Other principal transactions for positions in
Investing & Lending. See Notes 5 through 8 for further information about fair value measurements.
Investment Banking. Fees from financial advisory assignments and underwriting revenues are recognized in earnings when the services related to the underlying transaction are completed under the terms of the assignment.
Expenses associated with such transactions are deferred until the related revenue is recognized or the assignment is otherwise concluded. Expenses associated with financial advisory assignments are recorded as non-compensation expenses, net of
client reimbursements. Underwriting revenues are presented net of related expenses.
Investment Management. The firm earns management fees and incentive fees for investment management services. Management fees for mutual funds are
calculated as a percentage of daily net asset value and are received monthly. Management fees for hedge funds and separately managed accounts are calculated as a percentage of month-end net asset value and are generally received quarterly.
Management fees for private equity funds are calculated as a percentage of monthly invested capital or commitments and are received quarterly, semi-annually or annually, depending on the fund. All management fees are recognized over the period that
the related service is provided. Incentive fees are calculated as a percentage of a funds or separately managed accounts return, or excess return above a specified benchmark or other performance target. Incentive fees are generally based
on investment performance over a 12-month period or over the life of a fund. Fees that are based on performance over a 12-month period are subject to adjustment prior to the end of the measurement period. For fees that are based on investment
performance over the life of the fund, future investment underperformance may require fees previously distributed to the firm to be returned to the fund. Incentive fees are recognized only when all material contingencies have been resolved.
Management and incentive fee revenues are included in Investment management revenues.
The firm makes payments to
brokers and advisors related to the placement of the firms investment funds. These payments are computed based on either a percentage of the management fee or the investment funds net asset value. Where the firm is principal to the
arrangement, such costs are recorded on a gross basis and included in Brokerage, clearing, exchange and distribution fees, and where the firm is agent to the arrangement, such costs are recorded on a net basis in Investment
management revenues.
|
|
|
|
|
|
|
Goldman Sachs June 2014 Form 10-Q |
|
9 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Commissions and Fees. The firm earns Commissions and fees from executing and clearing client transactions on stock, options and futures markets. Commissions and fees are recognized on the day the trade is
executed.
Transfers of Assets
Transfers of assets are accounted for as sales when the firm has relinquished control over the assets transferred. For transfers of assets accounted for as sales, any related gains or losses are
recognized in net revenues. Assets or liabilities that arise from the firms continuing involvement with transferred assets are measured at fair value. For transfers of assets that are not accounted for as sales, the assets remain in
Financial instruments owned, at fair value and the transfer is accounted for as a collateralized financing, with the related interest expense recognized over the life of the transaction. See Note 9 for further information about
transfers of assets accounted for as collateralized financings and Note 10 for further information about transfers of assets accounted for as sales.
Cash and Cash Equivalents
The firm
defines cash equivalents as highly liquid overnight deposits held in the ordinary course of business. As of June 2014 and December 2013, Cash and cash equivalents included $6.26 billion and $4.14 billion,
respectively, of cash and due from banks, and $50.72 billion and $56.99 billion, respectively, of interest-bearing deposits with banks.
Receivables from Customers and Counterparties
Receivables from customers and counterparties generally relate to collateralized transactions. Such receivables are primarily comprised of customer margin loans, certain transfers of assets accounted for
as secured loans rather than purchases at fair value, collateral posted in connection with certain derivative transactions, and loans held for investment. Certain of the firms receivables from customers and counterparties are accounted for at
fair value under the fair value option, with changes in fair value generally included in Market making revenues. Receivables from customers and counterparties not accounted for at fair value, including loans held for investment, are
accounted for at amortized cost net of estimated uncollectible amounts. Interest on receivables from customers and counterparties is recognized over the life of the transaction and included in Interest income. See Note 8 for further
information about receivables from customers and counterparties.
Receivables from and Payables to Brokers, Dealers and Clearing Organizations
Receivables from and payables to brokers, dealers and clearing organizations are accounted for at cost plus accrued interest, which
generally approximates fair value. While these receivables and payables are carried at amounts that approximate fair value, they are not accounted for at fair value under the fair value option or at fair value in accordance with other U.S. GAAP and
therefore are not included in the firms fair value hierarchy in Notes 6, 7 and 8. Had these receivables and payables been included in the firms fair value hierarchy, substantially all would have been classified in level 2 as of
June 2014 and December 2013.
Payables to Customers and Counterparties
Payables to customers and counterparties primarily consist of customer credit balances related to the firms prime brokerage
activities. Payables to customers and counterparties are accounted for at cost plus accrued interest, which generally approximates fair value. While these payables are carried at amounts that approximate fair value, they are not accounted for at
fair value under the fair value option or at fair value in accordance with other U.S. GAAP and therefore are not included in the firms fair value hierarchy in Notes 6, 7 and 8. Had these payables been included in the firms fair
value hierarchy, substantially all would have been classified in level 2 as of June 2014 and December 2013.
|
|
|
|
|
10 |
|
Goldman Sachs June 2014 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Offsetting Assets and Liabilities
To reduce credit exposures on derivatives and securities financing transactions, the firm may enter into master netting agreements or similar arrangements (collectively, netting agreements) with
counterparties that permit it to offset receivables and payables with such counterparties. A netting agreement is a contract with a counterparty that permits net settlement of multiple transactions with that counterparty, including upon the exercise
of termination rights by a non-defaulting party. Upon exercise of such termination rights, all transactions governed by the netting agreement are terminated and a net settlement amount is calculated. In addition, the firm receives and posts cash and
securities collateral with respect to its derivatives and securities financing transactions, subject to the terms of the related credit support agreements or similar arrangements (collectively, credit support agreements). An enforceable credit
support agreement grants the non-defaulting party exercising termination rights the right to liquidate the collateral and apply the proceeds to any amounts owed. In order to assess enforceability of the firms right of setoff under netting and
credit support agreements, the firm evaluates various factors including applicable bankruptcy laws, local statutes and regulatory provisions in the jurisdiction of the parties to the agreement.
Derivatives are reported on a net-by-counterparty basis (i.e., the net payable or receivable for derivative assets and liabilities for a
given counterparty) in the condensed consolidated statements of financial condition when a legal right of setoff exists under an enforceable netting agreement. Resale and repurchase agreements and securities borrowed and loaned transactions with the
same term and currency are presented on a net-by-counterparty basis in the condensed consolidated statements of financial condition when such transactions meet certain settlement criteria and are subject to netting agreements.
In the condensed consolidated statements of financial condition, derivatives are reported net of cash collateral received and posted under
enforceable credit support agreements, when transacted under an enforceable netting agreement. In the condensed consolidated statements of financial condition, resale and repurchase agreements, and securities borrowed and loaned, are not
reported net of the related cash and securities received or posted as collateral. See Note 9 for further information about collateral received and pledged, including rights to deliver or repledge collateral. See Notes 7 and 9 for further
information about offsetting.
Share-based Compensation
The cost of employee services received in exchange for a share-based award is generally measured based on the grant-date fair value of the award. Share-based awards that do not require future service
(i.e., vested awards, including awards granted to retirement-eligible employees) are expensed immediately. Share-based awards that require future service are amortized over the relevant service period. Expected forfeitures are included in
determining share-based employee compensation expense.
The firm pays cash dividend equivalents on outstanding restricted stock
units (RSUs). Dividend equivalents paid on RSUs are generally charged to retained earnings. Dividend equivalents paid on RSUs expected to be forfeited are included in compensation expense. The firm accounts for the tax benefit related to dividend
equivalents paid on RSUs as an increase to additional paid-in capital.
The firm generally issues new shares of common stock
upon delivery of share-based awards. In certain cases, primarily related to conflicted employment (as outlined in the applicable award agreements), the firm may cash settle share-based compensation awards accounted for as equity instruments. For
these awards, whose terms allow for cash settlement, additional paid-in capital is adjusted to the extent of the difference between the value of the award at the time of cash settlement and the grant-date value of the award.
Foreign Currency Translation
Assets and liabilities denominated in non-U.S. currencies are translated at rates of exchange prevailing on the date of the condensed
consolidated statements of financial condition and revenues and expenses are translated at average rates of exchange for the period. Foreign currency remeasurement gains or losses on transactions in nonfunctional currencies are recognized in
earnings. Gains or losses on translation of the financial statements of a non-U.S. operation, when the functional currency is other than the U.S. dollar, are included, net of hedges and taxes, in the condensed consolidated statements of
comprehensive income.
|
|
|
|
|
|
|
Goldman Sachs June 2014 Form 10-Q |
|
11 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Recent Accounting Developments
Investment Companies (ASC
946). In June 2013, the FASB issued ASU No. 2013-08, Financial Services Investment Companies (Topic 946) Amendments to the Scope, Measurement,
and Disclosure Requirements. ASU No. 2013-08 clarifies the approach to be used for determining whether an entity is an investment company and provides new measurement and disclosure requirements.
ASU No. 2013-08 is effective for interim and annual reporting periods in fiscal years that begin after December 15, 2013. Adoption of ASU No. 2013-08 on January 1, 2014 did not affect the firms financial
condition, results of operations, or cash flows.
Inclusion of the Fed Funds
Effective Swap Rate (or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes (ASC 815). In July 2013, the FASB issued ASU No. 2013-10,
Derivatives and Hedging (Topic 815) Inclusion of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes. ASU No. 2013-10 permits the use of the
Fed Funds Effective Swap Rate (OIS) as a U.S. benchmark interest rate for hedge accounting purposes. The ASU also removes the restriction on using different benchmark rates for similar hedges. ASU No. 2013-10 was effective for qualifying new or
redesignated hedging relationships entered into on or after July 17, 2013 and adoption did not materially affect the firms financial condition, results of operations, or cash flows.
Revenue from Contracts with Customers
(ASC 606). In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). ASU No. 2014-09 provides comprehensive guidance on the recognition of revenue from customers arising from the transfer of goods and services. The ASU also provides guidance on accounting for certain contract costs,
and requires new disclosures. ASU No. 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. The firm is still
evaluating the effect of the ASU on its financial condition, results of operations, and cash flows.
Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosures (ASC 860). In June 2014, the FASB issued ASU No. 2014-11,
Transfers and Servicing (Topic 860): Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosures. ASU No. 2014-11 changes the accounting for repurchase- and resale-to-maturity agreements by requiring that such
agreements be recognized as financing arrangements, and requires that a transfer of a financial asset and a repurchase agreement entered into contemporaneously be accounted for separately. ASU No. 2014-11 also requires additional disclosures
about certain transferred financial assets accounted for as sales and certain securities financing transactions. The accounting changes and additional disclosures about certain transferred financial assets accounted for as sales are effective for
the first interim and annual reporting periods beginning after December 15, 2014. The additional disclosures for securities financing transactions are required for annual reporting periods beginning after December 15, 2014 and
for interim reporting periods beginning after March 15, 2015. Early adoption is not permitted. Adoption of ASU No. 2014-11 is not expected to materially affect the firms financial condition, results of operations, or cash flows.
|
|
|
|
|
12 |
|
Goldman Sachs June 2014 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
|
|
|
|
|
Note 4.
Financial Instruments Owned, at Fair Value and Financial Instruments Sold, But Not Yet Purchased, at Fair Value |
|
|
|
|
Financial instruments owned, at fair value and financial instruments sold, but not yet
purchased, at fair value are accounted for at fair value either under the fair value option or in accordance with other U.S. GAAP. See Note 8 for further information about other financial assets and
financial liabilities accounted for at fair value primarily under the fair value option. The table below presents the firms financial instruments owned, at fair value, including those
pledged as collateral, and financial instruments sold, but not yet purchased, at fair value.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of June 2014 |
|
|
|
|
As of December 2013 |
|
in millions |
|
|
Financial Instruments Owned |
|
|
|
Financial Instruments Sold, But Not Yet Purchased |
|
|
|
|
|
Financial Instruments Owned |
|
|
|
Financial Instruments Sold, But Not Yet Purchased |
|
Commercial paper, certificates of deposit, time deposits and other money market instruments |
|
|
$ 6,537 |
|
|
|
$ |
|
|
|
|
|
$ 8,608 |
|
|
|
$ |
|
|
|
U.S. government and federal agency obligations |
|
|
75,648 |
|
|
|
15,734 |
|
|
|
|
|
71,072 |
|
|
|
20,920 |
|
|
|
Non-U.S. government and agency obligations |
|
|
44,787 |
|
|
|
24,786 |
|
|
|
|
|
40,944 |
|
|
|
26,999 |
|
|
|
Mortgage and other asset-backed loans and securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loans and securities backed by commercial real estate |
|
|
6,374 |
|
|
|
21 |
|
|
|
|
|
6,596 |
|
|
|
1 |
|
|
|
Loans and securities backed by residential real estate |
|
|
9,857 |
|
|
|
1 |
|
|
|
|
|
9,025 |
|
|
|
2 |
|
|
|
Bank loans and bridge loans |
|
|
18,731 |
|
|
|
732 |
1 |
|
|
|
|
17,400 |
|
|
|
925 |
1 |
|
|
Corporate debt securities |
|
|
23,459 |
|
|
|
5,505 |
|
|
|
|
|
17,412 |
|
|
|
5,253 |
|
|
|
State and municipal obligations |
|
|
1,406 |
|
|
|
|
|
|
|
|
|
1,476 |
|
|
|
51 |
|
|
|
Other debt obligations |
|
|
3,645 |
|
|
|
31 |
|
|
|
|
|
3,129 |
|
|
|
4 |
|
|
|
Equities and convertible debentures |
|
|
97,462 |
|
|
|
29,331 |
|
|
|
|
|
101,024 |
|
|
|
22,583 |
|
|
|
Commodities |
|
|
4,057 |
|
|
|
1,826 |
|
|
|
|
|
4,556 |
|
|
|
966 |
|
Subtotal |
|
|
291,963 |
|
|
|
77,967 |
|
|
|
|
|
281,242 |
|
|
|
77,704 |
|
|
|
Derivatives |
|
|
53,843 |
|
|
|
46,195 |
|
|
|
|
|
57,879 |
|
|
|
49,722 |
|
Total |
|
|
$345,806 |
|
|
|
$124,162 |
|
|
|
|
|
$339,121 |
|
|
|
$127,426 |
|
1. |
Primarily relates to the fair value of unfunded lending commitments for which the fair value option was elected. |
|
|
|
|
|
|
|
Goldman Sachs June 2014 Form 10-Q |
|
13 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Gains and Losses from Market Making and Other Principal Transactions
The table below presents Market making revenues by major product type, as well as Other principal transactions
revenues. These gains/(losses) are primarily related to the firms financial instruments owned, at fair value and financial instruments sold, but not yet purchased, at fair value, including both derivative and non-derivative financial
instruments. These gains/(losses) exclude related interest income and interest expense. See Note 23 for further information about interest income and interest expense.
The gains/(losses) in the table below are not representative of the manner in which the firm manages its business activities because many
of the firms market-making and client facilitation strategies utilize financial instruments across various product types. Accordingly, gains or losses in one product type frequently offset gains or losses in other product types. For example,
most of the firms longer-term derivatives across product types are sensitive to changes in interest rates and may be economically hedged with interest rate swaps. Similarly, a significant portion of the firms cash instruments and
derivatives across product types has exposure to foreign currencies and may be economically hedged with foreign currency contracts.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
in millions Product Type |
|
Three Months Ended June |
|
|
|
|
Six Months
Ended June |
|
|
|
2014 |
|
|
|
2013 |
|
|
|
|
|
2014 |
|
|
|
2013 |
|
Interest rates |
|
|
$ (176 |
) |
|
|
$ 131 |
|
|
|
|
|
$ (456 |
) |
|
|
$(1,033 |
) |
|
|
Credit |
|
|
1,022 |
|
|
|
(5 |
) |
|
|
|
|
2,202 |
|
|
|
1,454 |
|
|
|
Currencies |
|
|
561 |
|
|
|
851 |
|
|
|
|
|
856 |
|
|
|
3,360 |
|
|
|
Equities |
|
|
544 |
|
|
|
767 |
|
|
|
|
|
1,227 |
|
|
|
1,269 |
|
|
|
Commodities |
|
|
234 |
|
|
|
261 |
|
|
|
|
|
995 |
|
|
|
649 |
|
|
|
Other |
|
|
|
|
|
|
687 |
2 |
|
|
|
|
|
|
|
|
430 |
2 |
Market making |
|
|
2,185 |
|
|
|
2,692 |
|
|
|
|
|
4,824 |
|
|
|
6,129 |
|
Other principal transactions 1 |
|
|
1,995 |
|
|
|
1,402 |
|
|
|
|
|
3,498 |
|
|
|
3,483 |
|
Total |
|
|
$4,180 |
|
|
|
$4,094 |
|
|
|
|
|
$8,322 |
|
|
|
$ 9,612 |
|
1. |
Other principal transactions are included in the firms Investing & Lending segment. See Note 25 for net revenues, including net interest
income, by product type for Investing & Lending, as well as the amount of net interest income included in Investing & Lending. The Other category in Note 25 relates to the firms consolidated investment
entities, and primarily includes commodities-related net revenues. |
2. |
Includes gains on insurance liabilities related to the firms European insurance business, which were offset by losses on the related hedges in other
product types. |
Note 5.
Fair Value Measurements
The fair value of a financial instrument is the amount that
would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. Fair
value measurements do not include transaction costs. The firm measures certain financial assets and financial liabilities as a portfolio (i.e., based on its net exposure to market and/or credit risks).
The best evidence of fair value is a quoted price in an active market. If quoted prices in active markets are not available, fair value is
determined by reference to prices for similar instruments, quoted prices or recent transactions in less active markets, or internally developed models that primarily use market-based or independently sourced parameters as inputs including, but not
limited to, interest rates, volatilities, equity or debt prices, foreign exchange rates, commodity prices, credit spreads and funding spreads (i.e., the spread, or difference, between the interest rate at which a borrower could finance a given
financial instrument relative to a benchmark interest rate).
U.S. GAAP has a three-level fair value hierarchy for disclosure
of fair value measurements. The fair value hierarchy prioritizes inputs to the valuation techniques used to measure fair value, giving the highest priority to level 1 inputs and the lowest priority to level 3 inputs. A financial
instruments level in the fair value hierarchy is based on the lowest level of input that is significant to its fair value measurement.
|
|
|
|
|
14 |
|
Goldman Sachs June 2014 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
The fair value hierarchy is as follows:
Level 1. Inputs are
unadjusted quoted prices in active markets to which the firm had access at the measurement date for identical, unrestricted assets or liabilities.
Level 2. Inputs to valuation techniques are observable, either directly or indirectly.
Level 3.
One or more inputs to valuation techniques are significant and unobservable.
The fair values for substantially all of the
firms financial assets and financial liabilities are based on observable prices and inputs and are classified in levels 1 and 2 of the fair value hierarchy. Certain level 2 and level 3 financial assets and financial liabilities
may require appropriate valuation adjustments that a market participant would require to arrive at fair value for factors such as counterparty and the firms credit quality, funding risk, transfer restrictions, liquidity and bid/offer spreads.
Valuation adjustments are generally based on market evidence.
See Notes 6, 7 and 8 for further information about fair
value measurements of cash instruments, derivatives and other financial assets and financial liabilities accounted for at fair value primarily under the fair value option (including information about significant unrealized gains and losses related
to level 3 financial assets and financial liabilities, and transfers in and out of level 3), respectively.
The table below presents financial assets and financial liabilities accounted for at fair
value under the fair value option or in accordance with other U.S. GAAP. In the table below, counterparty and cash collateral netting represents the impact on derivatives of netting across levels of the fair value hierarchy. Netting among positions
classified in the same level is included in that level.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of |
|
$ in millions |
|
|
June
2014 |
|
|
|
March
2014 |
|
|
|
December 2013 |
|
Total level 1 financial assets |
|
|
$153,025 |
|
|
|
$153,199 |
|
|
|
$156,030 |
|
|
|
Total level 2 financial assets |
|
|
441,295 |
|
|
|
484,573 |
|
|
|
499,480 |
|
|
|
Total level 3 financial assets |
|
|
39,760 |
|
|
|
40,923 |
|
|
|
40,013 |
|
|
|
Counterparty and cash collateral netting |
|
|
(96,842 |
) |
|
|
(92,834 |
) |
|
|
(95,350 |
) |
Total financial assets at fair value |
|
|
$537,238 |
|
|
|
$585,861 |
|
|
|
$600,173 |
|
|
|
Total assets 1 |
|
|
$859,914 |
|
|
|
$915,665 |
|
|
|
$911,507 |
|
|
|
Total level 3 financial assets as a percentage of Total assets |
|
|
4.6% |
|
|
|
4.5% |
|
|
|
4.4% |
|
|
|
Total level 3 financial assets as a percentage of Total financial assets at fair value |
|
|
7.4% |
|
|
|
7.0% |
|
|
|
6.7% |
|
|
|
Total level 1 financial liabilities |
|
|
$ 67,579 |
|
|
|
$ 71,973 |
|
|
|
$ 68,412 |
|
|
|
Total level 2 financial liabilities |
|
|
247,288 |
|
|
|
273,929 |
|
|
|
300,583 |
|
|
|
Total level 3 financial liabilities |
|
|
12,389 |
|
|
|
13,208 |
|
|
|
12,046 |
|
|
|
Counterparty and cash collateral netting |
|
|
(27,811 |
) |
|
|
(25,415 |
) |
|
|
(25,868 |
) |
Total financial liabilities at fair value |
|
|
$299,445 |
|
|
|
$333,695 |
|
|
|
$355,173 |
|
|
|
Total level 3 financial liabilities as a percentage of Total financial liabilities at
fair value |
|
|
4.1% |
|
|
|
4.0% |
|
|
|
3.4% |
|
1. |
Includes approximately $837 billion, $892 billion and $890 billion as of June 2014, March 2014 and December 2013, respectively,
that is carried at fair value or at amounts that generally approximate fair value. |
Level 3 financial
assets as of June 2014 decreased compared with March 2014, primarily reflecting a decrease in bank loans and bridge loans and derivative assets. The decrease in bank loans and bridge loans primarily reflected settlements and sales,
partially offset by purchases, realized gains and net transfers from level 2. The decrease in derivative assets primarily reflected a decline in credit derivative assets, principally due to settlements and unrealized losses.
Level 3 financial assets as of June 2014 were essentially unchanged compared with December 2013.
|
|
|
|
|
|
|
Goldman Sachs June 2014 Form 10-Q |
|
15 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note 6.
Cash Instruments
Cash instruments include U.S. government and federal agency obligations, non-U.S.
government and agency obligations, bank loans and bridge loans, corporate debt securities, equities and convertible debentures, and other non-derivative financial instruments owned and financial instruments sold, but not yet purchased. See below for
the types of cash instruments included in each level of the fair value hierarchy and the valuation techniques and significant inputs used to determine their fair values. See Note 5 for an overview of the firms fair value
measurement policies.
Level 1 Cash Instruments
Level 1 cash instruments include U.S. government obligations and most non-U.S. government obligations, actively traded listed equities, certain government agency obligations and money market
instruments. These instruments are valued using quoted prices for identical unrestricted instruments in active markets.
The
firm defines active markets for equity instruments based on the average daily trading volume both in absolute terms and relative to the market capitalization for the instrument. The firm defines active markets for debt instruments based on both the
average daily trading volume and the number of days with trading activity.
Level 2 Cash Instruments
Level 2 cash instruments include commercial paper, certificates of deposit, time deposits, most government agency obligations,
certain non-U.S. government obligations, most corporate debt securities, commodities, certain mortgage-backed loans and securities, certain bank loans and bridge loans, restricted or less liquid listed equities, most state and municipal obligations
and certain lending commitments.
Valuations of level 2 cash instruments can be verified to quoted prices, recent
trading activity for identical or similar instruments, broker or dealer quotations or alternative pricing sources with reasonable levels of price transparency. Consideration is given to the nature of the quotations (e.g., indicative or firm)
and the relationship of recent market activity to the prices provided from alternative pricing sources.
Valuation
adjustments are typically made to level 2 cash instruments (i) if the cash instrument is subject to transfer restrictions and/or (ii) for other premiums and liquidity discounts that a market participant would require to arrive at fair
value. Valuation adjustments are generally based on market evidence.
Level 3 Cash Instruments
Level 3 cash instruments have one or more significant valuation inputs that are not observable. Absent evidence to the contrary,
level 3 cash instruments are initially valued at transaction price, which is considered to be the best initial estimate of fair value. Subsequently, the firm uses other methodologies to determine fair value, which vary based on the type of
instrument. Valuation inputs and assumptions are changed when corroborated by substantive observable evidence, including values realized on sales of financial assets.
|
|
|
|
|
16 |
|
Goldman Sachs June 2014 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Valuation Techniques and Significant Inputs
The table below presents the valuation techniques and the nature of significant inputs.
These valuation techniques and
significant inputs are generally used to determine the fair values of each type of level 3 cash instrument.
|
|
|
|
|
Level 3 Cash Instruments |
|
|
|
Valuation Techniques and Significant Inputs |
Loans and
securities backed by commercial real estate
Collateralized by a single commercial real estate property or a portfolio of properties
May include tranches of varying levels of subordination |
|
|
|
Valuation techniques vary by instrument, but are generally based on discounted cash flow techniques. |
|
|
|
Significant inputs are generally determined based on relative value analyses and include: |
|
|
|
Transaction prices in both the underlying collateral and instruments with the same or similar underlying collateral and the basis, or price difference, to such
prices |
|
|
|
Market yields implied by transactions of similar or related assets and/or current levels and changes in market indices such as the CMBX (an index that tracks the performance of
commercial mortgage bonds) |
|
|
|
A measure of expected future cash flows in a default scenario (recovery rates) implied by the value of the underlying collateral, which is mainly driven by current performance of the
underlying collateral, capitalization rates and multiples. Recovery rates are expressed as a percentage of notional or face value of the instrument and reflect the benefit of credit enhancements on certain instruments |
|
|
|
Timing of expected future cash flows (duration) which, in certain cases, may incorporate the impact of other unobservable inputs (e.g., prepayment speeds)
|
Loans and securities backed by residential real estate
Collateralized by portfolios of residential real estate
May include tranches of varying levels of subordination |
|
|
|
Valuation techniques vary by instrument, but are generally based on discounted cash flow techniques. |
|
|
|
Significant inputs are generally determined based on relative value analyses, which incorporate comparisons to instruments with similar collateral
and risk profiles. Significant inputs include: |
|
|
|
Transaction prices in both the underlying collateral and instruments with the same or similar underlying collateral |
|
|
|
Market yields implied by transactions of similar or related assets |
|
|
|
Cumulative loss expectations, driven by default rates, home price projections, residential property liquidation timelines and related costs |
|
|
|
Duration, driven by underlying loan prepayment speeds and residential property liquidation timelines
|
Bank loans and bridge loans |
|
|
|
Valuation techniques vary by instrument, but are generally based on discounted cash flow techniques. |
|
|
|
Significant inputs are generally determined based on relative value analyses, which incorporate comparisons both to prices of credit default swaps
that reference the same or similar underlying instrument or entity and to other debt instruments for the same issuer for which observable prices or broker quotations are available. Significant inputs include: |
|
|
|
Market yields implied by transactions of similar or related assets and/or current levels and trends of market indices such as CDX and LCDX (indices that track the performance of
corporate credit and loans, respectively) |
|
|
|
Current performance and recovery assumptions and, where the firm uses credit default swaps to value the related cash instrument, the cost of borrowing the underlying reference
obligation |
|
|
|
Duration |
Non-U.S. government and agency obligations
Corporate debt securities
State and municipal obligations
Other debt obligations |
|
|
|
Valuation techniques vary by instrument, but are generally based on discounted cash flow techniques. |
|
|
|
Significant inputs are generally determined based on relative value analyses, which incorporate comparisons both to prices of credit default swaps
that reference the same or similar underlying instrument or entity and to other debt instruments for the same issuer for which observable prices or broker quotations are available. Significant inputs include: |
|
|
|
Market yields implied by transactions of similar or related assets and/or current levels and trends of market indices such as CDX, LCDX and MCDX (an index that tracks the performance
of municipal obligations) |
|
|
|
Current performance and recovery assumptions and, where the firm uses credit default swaps to value the related cash instrument, the cost of borrowing the underlying reference
obligation |
|
|
|
Duration |
Equities and convertible debentures (including private equity investments and investments in real estate entities) |
|
|
|
Recent third-party completed or pending transactions (e.g., merger proposals, tender offers, debt restructurings) are considered to be the best evidence for any change in fair value. When these are not available,
the following valuation methodologies are used, as appropriate: |
|
|
Industry multiples (primarily EBITDA multiples) and public comparables |
|
|
Transactions in similar instruments |
|
|
Discounted cash flow techniques |
|
|
Third-party appraisals |
|
|
Net asset value per share (NAV) |
|
|
The
firm also considers changes in the outlook for the relevant industry and financial performance of the issuer as compared to projected performance. Significant inputs include: |
|
|
Market and transaction multiples |
|
|
Discount rates, long-term growth rates, earnings compound annual growth rates and capitalization rates |
|
|
For equity instruments with debt-like features: market yields implied by transactions of similar or related
assets, current performance and recovery assumptions, and duration |
|
|
|
|
|
|
|
Goldman Sachs June 2014 Form 10-Q |
|
17 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Significant Unobservable Inputs
The tables below present the ranges of significant unobservable inputs used to value the
firms level 3 cash instruments. These ranges represent the significant unobservable inputs that were used in the valuation of each type of cash instrument. Weighted averages in the tables below are calculated by weighting each input by
the relative fair value of the respective financial instruments. The ranges and weighted averages of these inputs are not representative of the appropriate inputs to use when
calculating the fair value of any one cash instrument. For example, the highest multiple presented in the tables below for private equity investments is appropriate for valuing a specific private
equity investment but may not be appropriate for valuing any other private equity investment. Accordingly, the ranges of inputs presented below do not represent uncertainty in, or possible ranges of, fair value measurements of the firms
level 3 cash instruments.
|
|
|
|
|
|
|
|
|
Level 3 Cash
Instruments |
|
|
|
Level 3 Assets
as of June 2014 (in millions) |
|
Valuation Techniques
and Significant Unobservable Inputs |
|
Range of Significant Unobservable Inputs (Weighted Average) as of June 2014 |
Loans and
securities backed by commercial real estate Collateralized by a single commercial real estate property or a portfolio of properties
May include tranches of varying levels of subordination
|
|
|
|
$2,620 |
|
Discounted cash flows: |
|
|
|
|
|
|
|
Yield |
|
3.5% to 20.0% (10.0%) |
|
|
|
|
|
Recovery rate |
|
24.6% to 97.4% (70.8%) |
|
|
|
|
|
Duration (years) |
|
0.2
to 5.3 (2.2) |
|
|
|
|
|
Basis |
|
(2)
points to 18 points (4 points) |
Loans and securities backed by residential real estate
Collateralized by portfolios of residential real estate
May include tranches of varying levels of subordination |
|
|
|
$2,039 |
|
Discounted cash
flows: |
|
|
|
|
|
|
|
Yield |
|
2.9% to 17.5% (9.1%) |
|
|
|
|
|
Cumulative loss rate |
|
8.0% to 89.6% (25.4%) |
|
|
|
|
|
Duration (years) |
|
1.2
to 10.5 (3.1) |
Bank loans and bridge loans |
|
|
|
$8,947 |
|
Discounted cash
flows: |
|
|
|
|
|
|
|
Yield |
|
1.6% to 23.4% (8.2%) |
|
|
|
|
|
Recovery rate |
|
34.7% to 87.1% (60.5%) |
|
|
|
|
|
Duration (years) |
|
0.4
to 4.5 (1.7) |
Non-U.S. government and agency obligations
Corporate debt securities State and municipal obligations Other debt
obligations |
|
|
|
$3,181 |
|
Discounted cash
flows: |
|
|
|
|
|
|
|
Yield |
|
1.0% to 24.0% (8.5%) |
|
|
|
|
|
Recovery rate |
|
0.0% to 70.0% (63.2%) |
|
|
|
|
|
Duration (years) |
|
1.0
to 16.7 (4.5) |
Equities and convertible debentures (including private equity
investments and investments in real estate entities) |
|
|
|
$16,259 1 |
|
Comparable
multiples: |
|
|
|
|
|
|
Multiples |
|
0.8x to 19.0x (6.6x) |
|
|
|
|
Discounted cash flows: |
|
|
|
|
|
|
Discount rate/yield |
|
5.5% to 25.0% (14.6%) |
|
|
|
|
Long-term growth rate/compound annual growth rate |
|
(3.5)% to 20.0% (7.1%) |
|
|
|
|
Capitalization rate |
|
5.1% to 12.1% (7.2%) |
1. |
The fair value of any one instrument may be determined using multiple valuation techniques. For example, market comparables and discounted cash flows may be
used together to determine fair value. Therefore, the level 3 balance encompasses both of these techniques. |
|
|
|
|
|
18 |
|
Goldman Sachs June 2014 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
|
|
|
|
|
|
|
|
|
Level 3 Cash Instruments
|
|
|
|
Level 3 Assets
as of December 2013 (in millions) |
|
Valuation Techniques and Significant Unobservable Inputs
|
|
Range of Significant Unobservable
Inputs (Weighted Average) as of December 2013
|
Loans and securities backed by commercial real estate
Collateralized by a single commercial real estate property or a portfolio of
properties
May include tranches of varying levels of subordination |
|
|
|
$2,692 |
|
Discounted cash
flows: |
|
|
|
|
|
|
Yield |
|
2.7% to 29.1% (10.1%) |
|
|
|
|
Recovery rate |
|
26.2% to 88.1% (74.4%) |
|
|
|
|
Duration (years) |
|
0.6
to 5.7 (2.0) |
|
|
|
|
Basis |
|
(9) points to 20 points (5 points) |
Loans and securities backed by residential
real estate
Collateralized by portfolios of residential real estate May include tranches of varying levels of subordination |
|
|
|
$1,961 |
|
Discounted cash
flows: |
|
|
|
|
|
|
Yield |
|
2.6% to 25.8% (10.1%) |
|
|
|
|
Cumulative loss rate |
|
9.8% to 56.6% (24.9%) |
|
|
|
|
Duration (years) |
|
1.4
to 16.7 (3.6) |
Bank loans and bridge loans |
|
|
|
$9,324 |
|
Discounted cash
flows: |
|
|
|
|
|
|
Yield |
|
1.0% to 39.6% (9.3%) |
|
|
|
|
Recovery rate |
|
40.0% to 85.0% (54.9%) |
|
|
|
|
Duration (years) |
|
0.5
to 5.3 (2.1) |
Non-U.S. government and agency obligations
Corporate debt securities State and municipal obligations Other debt
obligations |
|
|
|
$3,977 |
|
Discounted cash
flows: |
|
|
|
|
|
|
Yield |
|
1.5% to 40.2% (8.9%) |
|
|
|
|
Recovery rate |
|
0.0% to 70.0% (61.9%) |
|
|
|
|
Duration (years) |
|
0.6
to 16.1 (4.2) |
Equities and convertible debentures (including private equity
investments and investments in real estate entities) |
|
|
|
$14,685 1 |
|
Comparable
multiples: |
|
|
|
|
|
|
Multiples |
|
0.6x to 18.8x (6.9x) |
|
|
|
|
Discounted cash flows: |
|
|
|
|
|
|
Discount rate/yield |
|
6.0% to 29.1% (14.6%) |
|
|
|
|
Long-term growth rate/compound annual growth rate |
|
1.0% to 19.0% (8.1%) |
|
|
|
|
Capitalization rate |
|
4.6% to 11.3% (7.1%) |
1. |
The fair value of any one instrument may be determined using multiple valuation techniques. For example, market comparables and discounted cash flows may be
used together to determine fair value. Therefore, the level 3 balance encompasses both of these techniques. |
Increases in yield, discount rate, capitalization rate, duration or cumulative loss rate
used in the valuation of the firms level 3 cash instruments would result in a lower fair value measurement, while increases in recovery rate, basis, multiples, long-term growth rate or compound annual
growth rate would result in a higher fair value measurement. Due to the distinctive nature of each of the firms level 3 cash instruments, the interrelationship of inputs is not
necessarily uniform within each product type.
|
|
|
|
|
|
|
Goldman Sachs June 2014 Form 10-Q |
|
19 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Fair Value of Cash Instruments by Level
The tables below present, by level within the fair value hierarchy, cash instrument assets
and liabilities, at fair value. Cash instrument assets and liabilities are included in
Financial instruments owned, at fair value and Financial instruments sold, but not yet purchased, at fair value, respectively.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Instrument Assets at Fair Value as of June 2014 |
|
in millions |
|
|
Level 1 |
|
|
|
Level 2 |
|
|
|
Level 3 |
|
|
|
Total |
|
Commercial paper, certificates of deposit, time deposits and other money market instruments |
|
|
$ 183 |
|
|
|
$ 6,354 |
|
|
|
$ |
|
|
|
$ 6,537 |
|
|
|
U.S. government and federal agency obligations |
|
|
29,912 |
|
|
|
45,736 |
|
|
|
|
|
|
|
75,648 |
|
|
|
Non-U.S. government and agency obligations |
|
|
34,522 |
|
|
|
10,212 |
|
|
|
53 |
|
|
|
44,787 |
|
|
|
Mortgage and other asset-backed loans and
securities 1: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loans and securities backed by commercial real estate |
|
|
|
|
|
|
3,754 |
|
|
|
2,620 |
|
|
|
6,374 |
|
|
|
Loans and securities backed by residential real estate |
|
|
|
|
|
|
7,818 |
|
|
|
2,039 |
|
|
|
9,857 |
|
|
|
Bank loans and bridge loans |
|
|
|
|
|
|
9,784 |
|
|
|
8,947 |
|
|
|
18,731 |
|
|
|
Corporate debt securities 2 |
|
|
272 |
|
|
|
20,857 |
|
|
|
2,330 |
|
|
|
23,459 |
|
|
|
State and municipal obligations |
|
|
|
|
|
|
1,237 |
|
|
|
169 |
|
|
|
1,406 |
|
|
|
Other debt obligations 2 |
|
|
|
|
|
|
3,016 |
|
|
|
629 |
|
|
|
3,645 |
|
|
|
Equities and convertible debentures |
|
|
70,611 |
|
|
|
10,592 |
|
|
|
16,259 |
3 |
|
|
97,462 |
|
|
|
Commodities |
|
|
|
|
|
|
4,057 |
|
|
|
|
|
|
|
4,057 |
|
Total |
|
|
$135,500 |
|
|
|
$123,417 |
|
|
|
$33,046 |
|
|
|
$291,963 |
|
|
|
|
|
Cash Instrument Liabilities at Fair Value as of June 2014 |
|
in millions |
|
|
Level 1 |
|
|
|
Level 2 |
|
|
|
Level 3 |
|
|
|
Total |
|
U.S. government and federal agency obligations |
|
|
$ 15,616 |
|
|
|
$ 118 |
|
|
|
$ |
|
|
|
$ 15,734 |
|
|
|
Non-U.S. government and agency obligations |
|
|
22,997 |
|
|
|
1,789 |
|
|
|
|
|
|
|
24,786 |
|
|
|
Mortgage and other asset-backed loans and securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loans and securities backed by commercial real estate |
|
|
|
|
|
|
14 |
|
|
|
7 |
|
|
|
21 |
|
|
|
Loans and securities backed by residential real estate |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
1 |
|
|
|
Bank loans and bridge loans |
|
|
|
|
|
|
554 |
|
|
|
178 |
|
|
|
732 |
|
|
|
Corporate debt securities |
|
|
10 |
|
|
|
5,492 |
|
|
|
3 |
|
|
|
5,505 |
|
|
|
Other debt obligations |
|
|
|
|
|
|
29 |
|
|
|
2 |
|
|
|
31 |
|
|
|
Equities and convertible debentures |
|
|
28,901 |
|
|
|
423 |
|
|
|
7 |
|
|
|
29,331 |
|
|
|
Commodities |
|
|
|
|
|
|
1,826 |
|
|
|
|
|
|
|
1,826 |
|
Total |
|
|
$ 67,524 |
|
|
|
$ 10,246 |
|
|
|
$ 197 |
|
|
|
$ 77,967 |
|
1. |
Includes $317 million and $570 million of collateralized debt obligations (CDOs) backed by real estate in level 2 and level 3,
respectively. |
2. |
Includes $364 million and $1.05 billion of CDOs and collateralized loan obligations (CLOs) backed by corporate obligations in level 2 and
level 3, respectively. |
3. |
Includes $14.41 billion of private equity investments, $1.43 billion of investments in real estate entities and $416 million of convertible
debentures. |
|
|
|
|
|
20 |
|
Goldman Sachs June 2014 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Instrument Assets at Fair Value as of December 2013 |
|
in millions |
|
|
Level 1 |
|
|
|
Level 2 |
|
|
|
Level 3 |
|
|
|
Total |
|
Commercial paper, certificates of deposit, time deposits and other money market instruments |
|
|
$ 216 |
|
|
|
$ 8,392 |
|
|
|
$ |
|
|
|
$ 8,608 |
|
|
|
U.S. government and federal agency obligations |
|
|
29,582 |
|
|
|
41,490 |
|
|
|
|
|
|
|
71,072 |
|
|
|
Non-U.S. government and agency obligations |
|
|
29,451 |
|
|
|
11,453 |
|
|
|
40 |
|
|
|
40,944 |
|
|
|
Mortgage and other asset-backed loans and
securities 1: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loans and securities backed by commercial real estate |
|
|
|
|
|
|
3,904 |
|
|
|
2,692 |
|
|
|
6,596 |
|
|
|
Loans and securities backed by residential real estate |
|
|
|
|
|
|
7,064 |
|
|
|
1,961 |
|
|
|
9,025 |
|
|
|
Bank loans and bridge loans |
|
|
|
|
|
|
8,076 |
|
|
|
9,324 |
|
|
|
17,400 |
|
|
|
Corporate debt securities 2 |
|
|
240 |
|
|
|
14,299 |
|
|
|
2,873 |
|
|
|
17,412 |
|
|
|
State and municipal obligations |
|
|
|
|
|
|
1,219 |
|
|
|
257 |
|
|
|
1,476 |
|
|
|
Other debt obligations 2 |
|
|
|
|
|
|
2,322 |
|
|
|
807 |
|
|
|
3,129 |
|
|
|
Equities and convertible debentures |
|
|
76,945 |
|
|
|
9,394 |
|
|
|
14,685 |
3 |
|
|
101,024 |
|
|
|
Commodities |
|
|
|
|
|
|
4,556 |
|
|
|
|
|
|
|
4,556 |
|
Total |
|
|
$136,434 |
|
|
|
$112,169 |
|
|
|
$32,639 |
|
|
|
$281,242 |
|
|
|
|
|
Cash Instrument Liabilities at Fair Value as of December 2013 |
|
in millions |
|
|
Level 1 |
|
|
|
Level 2 |
|
|
|
Level 3 |
|
|
|
Total |
|
U.S. government and federal agency obligations |
|
|
$ 20,871 |
|
|
|
$ 49 |
|
|
|
$ |
|
|
|
$ 20,920 |
|
|
|
Non-U.S. government and agency obligations |
|
|
25,325 |
|
|
|
1,674 |
|
|
|
|
|
|
|
26,999 |
|
|
|
Mortgage and other asset-backed loans and securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loans and securities backed by commercial real estate |
|
|
|
|
|
|
|
|
|
|
1 |
|
|
|
1 |
|
|
|
Loans and securities backed by residential real estate |
|
|
|
|
|
|
2 |
|
|
|
|
|
|
|
2 |
|
|
|
Bank loans and bridge loans |
|
|
|
|
|
|
641 |
|
|
|
284 |
|
|
|
925 |
|
|
|
Corporate debt securities |
|
|
10 |
|
|
|
5,241 |
|
|
|
2 |
|
|
|
5,253 |
|
|
|
State and municipal obligations |
|
|
|
|
|
|
50 |
|
|
|
1 |
|
|
|
51 |
|
|
|
Other debt obligations |
|
|
|
|
|
|
3 |
|
|
|
1 |
|
|
|
4 |
|
|
|
Equities and convertible debentures |
|
|
22,107 |
|
|
|
468 |
|
|
|
8 |
|
|
|
22,583 |
|
|
|
Commodities |
|
|
|
|
|
|
966 |
|
|
|
|
|
|
|
966 |
|
Total |
|
|
$ 68,313 |
|
|
|
$ 9,094 |
|
|
|
$ 297 |
|
|
|
$ 77,704 |
|
1. |
Includes $295 million and $411 million of CDOs backed by real estate in level 2 and level 3, respectively. |
2. |
Includes $451 million and $1.62 billion of CDOs and CLOs backed by corporate obligations in level 2 and level 3, respectively.
|
3. |
Includes $12.82 billion of private equity investments, $1.37 billion of investments in real estate entities and $491 million of convertible
debentures. |
Transfers Between Levels of the Fair Value Hierarchy
Transfers between levels of the fair value hierarchy are reported at the beginning of the
reporting period in which they occur. During the three months ended June 2014, transfers into level 2 from level 1 of cash instruments were $552 million, including $346 million of public equity securities and
$206 million of U.S. government and federal agency obligations primarily due to decreased market activity in these instruments. During the three months ended June 2014, transfers into level 1 from level 2 of cash instruments were
$7 million, reflecting transfers of public equity securities due to increased market activity in these instruments. During the three months ended June 2013, transfers into level 2 from level 1 of cash instruments were
$51 million, primarily including transfers of public equity securities of $48 million due to decreased market activity in these instruments. During the three months ended June 2013, transfers into level 1 from level 2 of
cash instruments were $105 million, reflecting transfers of public equity securities, primarily due to increased market activity in these instruments.
During the six months ended June 2014, transfers into level 2 from level 1
of cash instruments were $67 million, including $49 million of public equity securities and $18 million of U.S. government and federal agency obligations primarily due to decreased market activity in these instruments. During the six
months ended June 2014, transfers into level 1 from level 2 of cash instruments were $81 million, reflecting transfers of public equity securities, due to increased market activity in these instruments. During the six months
ended June 2013, transfers into level 2 from level 1 of cash instruments were $5 million, reflecting transfers of public equity securities due to decreased market activity in these instruments. During the six months ended
June 2013, transfers into level 1 from level 2 of cash instruments were $77 million, reflecting transfers of public equity securities, primarily reflecting increased market activity in these instruments.
See level 3 rollforward below for information about transfers between level 2 and level 3.
|
|
|
|
|
|
|
Goldman Sachs June 2014 Form 10-Q |
|
21 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Level 3 Rollforward
If a cash instrument asset or liability was transferred to level 3 during a reporting
period, its entire gain or loss for the period is included in level 3.
Level 3 cash instruments are frequently
economically hedged with level 1 and level 2 cash instruments and/or level 1, level 2 or level 3 derivatives. Accordingly, gains or losses that are reported in level 3 can be partially offset by gains or losses
attributable to level 1 or level 2 cash
instruments and/or level 1, level 2 or level 3 derivatives. As a result, gains or losses included in the level 3 rollforward below do not necessarily represent the overall impact
on the firms results of operations, liquidity or capital resources.
The tables below present changes in fair value for
all cash instrument assets and liabilities categorized as level 3 as of the end of the period. Purchases in the tables below include both originations and secondary market purchases.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Level 3 Cash Instrument Assets at Fair Value for the Three Months Ended June 2014 |
|
in millions |
|
|
Balance, beginning of period |
|
|
|
Net realized gains/ (losses) |
|
|
|
Net unrealized gains/(losses) relating to instruments
still held at period-end |
|
|
|
Purchases |
|
|
|
Sales |
|
|
|
Settlements |
|
|
|
Transfers into
level 3 |
|
|
|
Transfers out of level 3 |
|
|
|
Balance, end of period |
|
Non-U.S. government and agency obligations |
|
|
$ 45 |
|
|
|
$ 1 |
|
|
|
$ 1 |
|
|
|
$ 9 |
|
|
|
$ (1 |
) |
|
|
$ (2 |
) |
|
|
$ |
|
|
|
$ |
|
|
|
$ 53 |
|
|
|
Mortgage and other asset-backed loans and securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loans and securities backed by commercial real estate |
|
|
2,626 |
|
|
|
31 |
|
|
|
90 |
|
|
|
114 |
|
|
|
(155 |
) |
|
|
(304 |
) |
|
|
417 |
|
|
|
(199 |
) |
|
|
2,620 |
|
|
|
Loans and securities backed by residential real estate |
|
|
2,065 |
|
|
|
34 |
|
|
|
90 |
|
|
|
149 |
|
|
|
(194 |
) |
|
|
(3 |
) |
|
|
27 |
|
|
|
(129 |
) |
|
|
2,039 |
|
|
|
Bank loans and bridge loans |
|
|
9,687 |
|
|
|
130 |
|
|
|
116 |
|
|
|
798 |
|
|
|
(272 |
) |
|
|
(1,641 |
) |
|
|
990 |
|
|
|
(861 |
) |
|
|
8,947 |
|
|
|
Corporate debt securities |
|
|
2,632 |
|
|
|
86 |
|
|
|
34 |
|
|
|
211 |
|
|
|
(666 |
) |
|
|
(177 |
) |
|
|
401 |
|
|
|
(191 |
) |
|
|
2,330 |
|
|
|
State and municipal obligations |
|
|
242 |
|
|
|
1 |
|
|
|
2 |
|
|
|
28 |
|
|
|
(41 |
) |
|
|
|
|
|
|
1 |
|
|
|
(64 |
) |
|
|
169 |
|
|
|
Other debt obligations |
|
|
640 |
|
|
|
5 |
|
|
|
32 |
|
|
|
53 |
|
|
|
(51 |
) |
|
|
(25 |
) |
|
|
41 |
|
|
|
(66 |
) |
|
|
629 |
|
|
|
Equities and convertible debentures |
|
|
15,807 |
|
|
|
76 |
|
|
|
939 |
|
|
|
590 |
|
|
|
(606 |
) |
|
|
(328 |
) |
|
|
796 |
|
|
|
(1,015 |
) |
|
|
16,259 |
|
Total |
|
|
$33,744 |
|
|
|
$364 |
1 |
|
|
$1,304 |
1 |
|
|
$1,952 |
|
|
|
$(1,986 |
) |
|
|
$(2,480 |
) |
|
|
$2,673 |
|
|
|
$(2,525 |
) |
|
|
$33,046 |
|
|
|
|
|
Level 3 Cash Instrument Liabilities at Fair Value for the Three Months Ended June 2014 |
|
in millions |
|
|
Balance, Beginning of period |
|
|
|
Net realized (gains)/ losses |
|
|
|
Net unrealized (gains)/losses relating to instruments still held at period-end |
|
|
|
Purchases |
|
|
|
Sales |
|
|
|
Settlements |
|
|
|
Transfers into level 3 |
|
|
|
Transfers out of level 3 |
|
|
|
Balance, end of period |
|
Total |
|
|
$ 204 |
|
|
|
$ (6 |
) |
|
|
$ (9 |
) |
|
|
$ (49 |
) |
|
|
$ 51 |
|
|
|
$ 11 |
|
|
|
$ 15 |
|
|
|
$ (20 |
) |
|
|
$ 197 |
|
1. |
The aggregate amounts include gains of approximately $232 million, $1.11 billion and $326 million reported in Market making,
Other principal transactions and Interest income, respectively. |
The net unrealized gain on level 3 cash instruments of $1.31 billion (reflecting
$1.30 billion on cash instrument assets and $9 million on cash instrument liabilities) for the three months ended June 2014 primarily consisted of gains on private equity investments principally driven by company-specific events and
strong corporate performance.
Transfers into level 3 during the three months ended June 2014 primarily reflected
transfers of certain bank loans and bridge loans and private equity investments from level 2 principally due to reduced price transparency as a result of a lack of market evidence, including fewer market transactions in these instruments.
Transfers out of level 3 during the three months ended June 2014 primarily
reflected transfers of certain private equity investments and bank loans and bridge loans to level 2 principally due to increased price transparency as a result of market evidence, including market transactions in these instruments.
|
|
|
|
|
22 |
|
Goldman Sachs June 2014 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Level 3 Cash Instrument Assets at Fair Value for the Six Months Ended June 2014 |
|
in millions |
|
|
Balance, beginning of period |
|
|
|
Net realized gains/ (losses) |
|
|
|
Net unrealized gains/(losses) relating to instruments still held at period-end |
|
|
|
Purchases |
|
|
|
Sales |
|
|
|
Settlements |
|
|
|
Transfers into level 3 |
|
|
|
Transfers out of level 3 |
|
|
|
Balance, end of period |
|
Non-U.S. government and agency obligations |
|
|
$ 40 |
|
|
|
$ 1 |
|
|
|
$ |
|
|
|
$ 22 |
|
|
|
$ (18 |
) |
|
|
$ (1 |
) |
|
|
$ 9 |
|
|
|
$ |
|
|
|
$ 53 |
|
|
|
Mortgage and other asset-backed loans and securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loans and securities backed by commercial real estate |
|
|
2,692 |
|
|
|
66 |
|
|
|
165 |
|
|
|
366 |
|
|
|
(259 |
) |
|
|
(461 |
) |
|
|
404 |
|
|
|
(353 |
) |
|
|
2,620 |
|
|
|
Loans and securities backed by residential real estate |
|
|
1,961 |
|
|
|
68 |
|
|
|
132 |
|
|
|
252 |
|
|
|
(177 |
) |
|
|
(178 |
) |
|
|
199 |
|
|
|
(218 |
) |
|
|
2,039 |
|
|
|
Bank loans and bridge loans |
|
|
9,324 |
|
|
|
244 |
|
|
|
236 |
|
|
|
2,250 |
|
|
|
(855 |
) |
|
|
(2,213 |
) |
|
|
651 |
|
|
|
(690 |
) |
|
|
8,947 |
|
|
|
Corporate debt securities |
|
|
2,873 |
|
|
|
155 |
|
|
|
66 |
|
|
|
629 |
|
|
|
(713 |
) |
|
|
(405 |
) |
|
|
100 |
|
|
|
(375 |
) |
|
|
2,330 |
|
|
|
State and municipal obligations |
|
|
257 |
|
|
|
2 |
|
|
|
4 |
|
|
|
34 |
|
|
|
(82 |
) |
|
|
(2 |
) |
|
|
1 |
|
|
|
(45 |
) |
|
|
169 |
|
|
|
Other debt obligations |
|
|
807 |
|
|
|
15 |
|
|
|
38 |
|
|
|
122 |
|
|
|
(160 |
) |
|
|
(76 |
) |
|
|
38 |
|
|
|
(155 |
) |
|
|
629 |
|
|
|
Equities and convertible debentures |
|
|
14,685 |
|
|
|
102 |
|
|
|
1,262 |
|
|
|
1,886 |
|
|
|
(1,025 |
) |
|
|
(597 |
) |
|
|
1,515 |
|
|
|
(1,569 |
) |
|
|
16,259 |
|
Total |
|
|
$32,639 |
|
|
|
$653 |
1 |
|
|
$1,903 |
1 |
|
|
$5,561 |
|
|
|
$(3,289 |
) |
|
|
$(3,933 |
) |
|
|
$2,917 |
|
|
|
$(3,405 |
) |
|
|
$33,046 |
|
|
|
|
|
Level 3 Cash Instrument Liabilities at Fair Value for the Six Months Ended June 2014 |
|
in millions |
|
|
Balance, Beginning of period |
|
|
|
Net realized (gains)/ losses |
|
|
|
Net unrealized (gains)/losses relating to instruments still held at period-end |
|
|
|
Purchases |
|
|
|
Sales |
|
|
|
Settlements |
|
|
|
Transfers into level 3 |
|
|
|
Transfers out of level 3 |
|
|
|
Balance, end of period |
|
Total |
|
|
$ 297 |
|
|
|
$ (6 |
) |
|
|
$ (70 |
) |
|
|
$ (110 |
) |
|
|
$ 71 |
|
|
|
$ 11 |
|
|
|
$ 5 |
|
|
|
$ (1 |
) |
|
|
$ 197 |
|
1. |
The aggregate amounts include gains of approximately $400 million, $1.56 billion and $597 million reported in Market making,
Other principal transactions and Interest income, respectively. |
The net unrealized gain on level 3 cash instruments of $1.97 billion (reflecting
$1.90 billion on cash instrument assets and $70 million on cash instrument liabilities) for the six months ended June 2014 primarily consisted of gains on private equity investments and bank loans and bridge loans, principally driven
by company-specific events and strong corporate performance.
Transfers into level 3 during the six months ended
June 2014 primarily reflected transfers of certain private equity investments and bank loans and bridge loans from level 2 principally due to reduced price transparency as a result of a lack of market evidence, including fewer market
transactions in these instruments.
Transfers out of level 3 during the six months ended June 2014 primarily
reflected transfers of certain private equity investments and bank loans and bridge loans to level 2 principally due to increased price transparency as a result of market evidence, including market transactions in these instruments.
|
|
|
|
|
|
|
Goldman Sachs June 2014 Form 10-Q |
|
23 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Level 3 Cash Instrument Assets at Fair Value for the Three Months Ended June 2013 |
|
in millions |
|
|
Balance, beginning of period |
|
|
|
Net realized gains/ (losses) |
|
|
|
Net unrealized gains/(losses) relating to instruments still held at period-end |
|
|
|
Purchases |
|
|
|
Sales |
|
|
|
Settlements |
|
|
|
Transfers into level 3 |
|
|
|
Transfers out of level 3 |
|
|
|
Balance, end of period |
|
Non-U.S. government and agency obligations |
|
|
$ 47 |
|
|
|
$ 2 |
|
|
|
$ 3 |
|
|
|
$ 42 |
|
|
|
$ (95 |
) |
|
|
$ |
|
|
|
$ 92 |
|
|
|
$ (1 |
) |
|
|
$ 90 |
|
|
|
Mortgage and other asset-backed loans and securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loans and securities backed by commercial real estate |
|
|
3,164 |
|
|
|
44 |
|
|
|
75 |
|
|
|
216 |
|
|
|
(431 |
) |
|
|
(258 |
) |
|
|
305 |
|
|
|
(146 |
) |
|
|
2,969 |
|
|
|
Loans and securities backed by residential real estate |
|
|
1,683 |
|
|
|
30 |
|
|
|
61 |
|
|
|
223 |
|
|
|
(163 |
) |
|
|
(156 |
) |
|
|
106 |
|
|
|
(46 |
) |
|
|
1,738 |
|
|
|
Bank loans and bridge loans |
|
|
11,688 |
|
|
|
160 |
|
|
|
180 |
|
|
|
1,530 |
|
|
|
(1,217 |
) |
|
|
(1,780 |
) |
|
|
518 |
|
|
|
(1,082 |
) |
|
|
9,997 |
|
|
|
Corporate debt securities |
|
|
2,442 |
|
|
|
63 |
|
|
|
58 |
|
|
|
365 |
|
|
|
(364 |
) |
|
|
(90 |
) |
|
|
187 |
|
|
|
(169 |
) |
|
|
2,492 |
|
|
|
State and municipal obligations |
|
|
334 |
|
|
|
2 |
|
|
|
3 |
|
|
|
58 |
|
|
|
(162 |
) |
|
|
|
|
|
|
93 |
|
|
|
(6 |
) |
|
|
322 |
|
|
|
Other debt obligations |
|
|
855 |
|
|
|
9 |
|
|
|
(3 |
) |
|
|
183 |
|
|
|
(92 |
) |
|
|
(132 |
) |
|
|
260 |
|
|
|
(204 |
) |
|
|
876 |
|
|
|
Equities and convertible debentures |
|
|
15,224 |
|
|
|
42 |
|
|
|
346 |
|
|
|
740 |
|
|
|
(178 |
) |
|
|
(330 |
) |
|
|
349 |
|
|
|
(776 |
) |
|
|
15,417 |
|
Total |
|
|
$35,437 |
|
|
|
$352 |
1 |
|
|
$723 |
1 |
|
|
$3,357 |
|
|
|
$(2,702 |
) |
|
|
$(2,746 |
) |
|
|
$1,910 |
|
|
|
$(2,430 |
) |
|
|
$33,901 |
|
|
|
|
|
Level 3 Cash Instrument Liabilities at Fair Value for the Three Months Ended June 2013 |
|
in millions |
|
|
Balance, beginning of period |
|
|
|
Net realized (gains)/ losses |
|
|
|
Net unrealized (gains)/losses relating to instruments still held at period-end |
|
|
|
Purchases |
|
|
|
Sales |
|
|
|
Settlements |
|
|
|
Transfers into level 3 |
|
|
|
Transfers out of level 3 |
|
|
|
Balance, end of period |
|
Total |
|
|
$ 441 |
|
|
|
$ 14 |
|
|
|
$ |
|
|
|
$ (210 |
) |
|
|
$ 89 |
|
|
|
$ 3 |
|
|
|
$ 75 |
|
|
|
$ (27 |
) |
|
|
$ 385 |
|
1. |
The aggregate amounts include gains of approximately $241 million, $612 million and $222 million reported in Market making,
Other principal transactions and Interest income, respectively. |
The net unrealized gain on level 3 cash instrument assets of $723 million for the
three months ended June 2013 primarily consisted of gains on private equity investments, primarily driven by company-specific events and strong corporate performance, and bank loans and bridge loans, primarily driven by company-specific events.
Transfers into level 3 during the three months ended June 2013 primarily reflected transfers from level 2 of
certain bank loans and bridge loans, private equity investments and investment in real estate entities, loans and securities backed by commercial real estate, and other debt obligations due to a lack of market transactions in these instruments.
Transfers out of level 3 during the three months ended June 2013 primarily
reflected transfers of certain bank loans and bridge loans and private equity investments to level 2, principally due to increased transparency of market prices as a result of market transactions in these instruments, and transfers related to
the firms European insurance business of certain level 3 bank loans and bridge loans within cash instruments to level 3 other assets within other financial assets at fair value, as this business was classified
as held for sale during the period.
|
|
|
|
|
24 |
|
Goldman Sachs June 2014 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Level 3 Cash Instrument Assets at Fair Value for the Six Months Ended June 2013 |
|
in millions |
|
|
Balance, beginning of period |
|
|
|
Net realized gains/ (losses) |
|
|
|
Net unrealized gains/(losses) relating to instruments still held at period-end |
|
|
|
Purchases |
|
|
|
Sales |
|
|
|
Settlements |
|
|
|
Transfers into level 3 |
|
|
|
Transfers out of level 3 |
|
|
|
Balance, end of period |
|
Non-U.S. government and agency obligations |
|
|
$ 26 |
|
|
|
$ 3 |
|
|
|
$ 6 |
|
|
|
$ 64 |
|
|
|
$ (9 |
) |
|
|
$ (2 |
) |
|
|
$ 5 |
|
|
|
$ (3 |
) |
|
|
$ 90 |
|
|
|
Mortgage and other asset-backed loans and securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loans and securities backed by commercial real estate |
|
|
3,389 |
|
|
|
60 |
|
|
|
132 |
|
|
|
391 |
|
|
|
(569 |
) |
|
|
(624 |
) |
|
|
385 |
|
|
|
(195 |
) |
|
|
2,969 |
|
|
|
Loans and securities backed by residential real estate |
|
|
1,619 |
|
|
|
65 |
|
|
|
79 |
|
|
|
475 |
|
|
|
(365 |
) |
|
|
(182 |
) |
|
|
124 |
|
|
|
(77 |
) |
|
|
1,738 |
|
|
|
Bank loans and bridge loans |
|
|
11,235 |
|
|
|
289 |
|
|
|
220 |
|
|
|
2,669 |
|
|
|
(1,163 |
) |
|
|
(3,007 |
) |
|
|
969 |
|
|
|
(1,215 |
) |
|
|
9,997 |
|
|
|
Corporate debt securities |
|
|
2,821 |
|
|
|
187 |
|
|
|
347 |
|
|
|
502 |
|
|
|
(1,183 |
) |
|
|
(290 |
) |
|
|
268 |
|
|
|
(160 |
) |
|
|
2,492 |
|
|
|
State and municipal obligations |
|
|
619 |
|
|
|
6 |
|
|
|
4 |
|
|
|
118 |
|
|
|
(421 |
) |
|
|
(2 |
) |
|
|
6 |
|
|
|
(8 |
) |
|
|
322 |
|
|
|
Other debt obligations |
|
|
1,185 |
|
|
|
22 |
|
|
|
18 |
|
|
|
423 |
|
|
|
(390 |
) |
|
|
(104 |
) |
|
|
160 |
|
|
|
(438 |
) |
|
|
876 |
|
|
|
Equities and convertible debentures |
|
|
14,855 |
|
|
|
86 |
|
|
|
920 |
|
|
|
968 |
|
|
|
(491 |
) |
|
|
(916 |
) |
|
|
1,097 |
|
|
|
(1,102 |
) |
|
|
15,417 |
|
Total |
|
|
$35,749 |
|
|
|
$718 |
1 |
|
|
$1,726 |
1 |
|
|
$5,610 |
|
|
|
$(4,591 |
) |
|
|
$(5,127 |
) |
|
|
$3,014 |
|
|
|
$(3,198 |
) |
|
|
$33,901 |
|
|
|
|
|
Level 3 Cash Instrument Liabilities at Fair Value for the Six Months Ended June 2013 |
|
in millions |
|
|
Balance, beginning of period |
|
|
|
Net realized gains/ (losses) |
|
|
|
Net unrealized gains/(losses) relating to instruments still held at period-end |
|
|
|
Purchases |
|
|
|
Sales |
|
|
|
Settlements |
|
|
|
Transfers into level 3 |
|
|
|
Transfers out of level 3 |
|
|
|
Balance, end of period |
|
Total |
|
|
$ 642 |
|
|
|
$ 47 |
|
|
|
$ |
|
|
|
$ (423 |
) |
|
|
$ 172 |
|
|
|
$ 7 |
|
|
|
$ 64 |
|
|
|
$ (124 |
) |
|
|
$ 385 |
|
1. |
The aggregate amounts include gains of approximately $662 million, $1.38 billion and $400 million reported in Market making,
Other principal transactions and Interest income, respectively. |
The net unrealized gain on level 3 cash instrument assets of $1.73 billion for
the six months ended June 2013 primarily consisted of gains on private equity investments, primarily driven by company-specific events and strong corporate performance, corporate debt securities, primarily due to tighter credit spreads, and
bank loans and bridge loans, primarily driven by company-specific events.
Transfers into level 3 during the six months
ended June 2013 primarily reflected transfers of certain private equity investments and bank loans and bridge loans from level 2, principally due to a lack of market transactions in these instruments.
Transfers out of level 3 during the six months ended June 2013 primarily
reflected transfers of certain bank loans and bridge loans, private equity investments and other debt obligations to level 2, principally due to increased transparency of market prices as a result of market transactions in these instruments,
and transfers related to the firms European insurance business of certain level 3 bank loans and bridge loans within cash instruments to level 3 other assets within other financial assets at fair value, as
this business was classified as held for sale during the period.
|
|
|
|
|
|
|
Goldman Sachs June 2014 Form 10-Q |
|
25 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
|
|
|
|
|
Investments in Funds That Are Calculated Using Net Asset Value Per Share |
|
|
|
|
Cash instruments at fair value include investments in funds that are calculated based on
the net asset value per share (NAV) of the investment fund. The firm uses NAV as its measure of fair value for fund investments when (i) the fund investment does not have a readily determinable fair value and (ii) the NAV of the investment
fund is calculated in a manner consistent with the measurement principles of investment company accounting, including measurement of the underlying investments at fair value.
The firms investments in funds that are calculated using NAV primarily consist of investments in firm-sponsored private equity, credit, real estate and hedge funds where the firm co-invests with
third-party investors.
Private equity funds primarily invest in a broad range of industries worldwide in a variety of
situations, including leveraged buyouts, recapitalizations, growth investments and distressed investments. Credit funds generally invest in loans and other fixed income instruments and are focused on providing private high-yield capital for mid- to
large-sized leveraged and management buyout transactions, recapitalizations, financings, refinancings, acquisitions and restructurings for private equity firms, private family companies and corporate issuers. Real estate funds invest globally,
primarily in real estate companies, loan portfolios, debt recapitalizations and property. The private equity, credit and real estate funds are primarily closed-end funds in which the firms investments are generally not eligible for redemption.
Distributions will be received from these funds as the underlying assets are liquidated.
The firm also invests in hedge funds,
primarily multi-disciplinary hedge funds that employ a fundamental bottom-up investment approach across various asset classes and strategies including long/short equity, credit, convertibles, risk arbitrage, special situations and capital structure
arbitrage. These investments in hedge funds are generally redeemable on a quarterly basis with 91 days notice, subject to a maximum redemption level of 25% of the firms initial investments at any quarter-end; however, these
investments also include interests where the underlying assets are illiquid in nature, and proceeds from redemptions will not be distributed until the underlying assets are liquidated.
Many of the funds described above are covered funds as defined by the Volcker
Rule of the U.S. Dodd-Frank Wall Street Reform and Consumer Protection Act (Dodd-Frank Act) which has a conformance period that ends in July 2015 subject to possible extensions through 2017.
The firm continues to manage its existing funds, taking into account the transition periods under the Volcker Rule.
In order to be compliant with the Volcker Rule, the firm will be required to reduce most of its interests in the funds in the table below
by the prescribed compliance date. To the extent that the underlying investments of particular funds are not sold, the firm may be required to sell its investments in such funds. If that occurs, the firm may receive a value for its investments that
is less than the then carrying value, as there could be a limited secondary market for these investments and the firm may be unable to sell them in orderly transactions.
Since March 2012, the firm has redeemed approximately $2.25 billion of its interests in hedge funds, including approximately $20 million and $60 million during the three and six months
ended June 2014, respectively.
The tables below present the fair value of the firms investments in, and unfunded
commitments to, funds that are calculated using NAV.
|
|
|
|
|
|
|
|
|
|
|
As of June 2014 |
|
in millions |
|
|
Fair Value of Investments |
|
|
|
Unfunded Commitments |
|
Private equity funds |
|
|
$ 7,510 |
|
|
|
$2,351 |
|
|
|
Credit funds |
|
|
3,001 |
|
|
|
1,683 |
|
|
|
Hedge funds |
|
|
1,461 |
|
|
|
|
|
|
|
Real estate funds |
|
|
1,773 |
|
|
|
382 |
|
Total |
|
|
$13,745 |
|
|
|
$4,416 |
|
|
|
|
|
As of December 2013 |
|
in millions |
|
|
Fair Value of Investments |
|
|
|
Unfunded Commitments |
|
Private equity funds |
|
|
$ 7,446 |
|
|
|
$2,575 |
|
|
|
Credit funds |
|
|
3,624 |
|
|
|
2,515 |
|
|
|
Hedge funds |
|
|
1,394 |
|
|
|
|
|
|
|
Real estate funds |
|
|
1,908 |
|
|
|
471 |
|
Total |
|
|
$14,372 |
|
|
|
$5,561 |
|
|
|
|
|
|
26 |
|
Goldman Sachs June 2014 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note 7.
Derivatives and Hedging Activities
Derivative Activities
Derivatives are instruments that derive their value from underlying asset prices, indices,
reference rates and other inputs, or a combination of these factors. Derivatives may be traded on an exchange (exchange-traded) or they may be privately negotiated contracts, which are usually referred to as over-the-counter (OTC) derivatives.
Certain of the firms OTC derivatives are cleared and settled through central clearing counterparties (OTC-cleared), while others are bilateral contracts between two counterparties (bilateral OTC).
Market-Making. As a
market maker, the firm enters into derivative transactions to provide liquidity to clients and to facilitate the transfer and hedging of their risks. In this capacity, the firm typically acts as principal and is consequently required to commit
capital to provide execution. As a market maker, it is essential to maintain an inventory of financial instruments sufficient to meet expected client and market demands.
Risk Management. The firm also enters into derivatives to actively manage risk exposures
that arise from its market-making and investing and lending activities in derivative and cash instruments. The firms holdings and exposures are hedged, in many cases, on either a portfolio or risk-specific basis, as opposed to an
instrument-by-instrument basis. The offsetting impact of this economic hedging is reflected in the same business segment as the related revenues. In addition, the firm may enter into derivatives designated as hedges under U.S. GAAP. These
derivatives are used to manage interest rate exposure in certain fixed-rate unsecured long-term and short-term borrowings, and deposits, to manage foreign currency exposure on the net investment in certain non-U.S. operations, and to manage the
exposure to the variability in cash flows associated with the forecasted sales of certain energy commodities by one of the firms consolidated investments.
The firm enters into various types of derivatives, including:
|
|
Futures and Forwards. Contracts
that commit counterparties to purchase or sell financial instruments, commodities or currencies in the future.
|
|
|
Swaps. Contracts that require
counterparties to exchange cash flows such as currency or interest payment streams. The amounts exchanged are based on the specific terms of the contract with reference to specified rates, financial instruments, commodities, currencies
or indices. |
|
|
Options. Contracts in which the
option purchaser has the right, but not the obligation, to purchase from or sell to the option writer financial instruments, commodities or currencies within a defined time period for a specified price. |
Derivatives are reported on a net-by-counterparty basis (i.e., the net payable or receivable for derivative assets and liabilities for a
given counterparty) when a legal right of setoff exists under an enforceable netting agreement (counterparty netting). Derivatives are accounted for at fair value, net of cash collateral received or posted under enforceable credit support agreements
(cash collateral netting). Derivative assets and liabilities are included in Financial instruments owned, at fair value and Financial instruments sold, but not yet purchased, at fair value, respectively. Substantially all
gains and losses on derivatives not designated as hedges under ASC 815 are included in Market making and Other principal transactions.
The tables below present the fair value of derivatives on a net-by-counterparty basis.
|
|
|
|
|
|
|
|
|
|
|
As of June 2014 |
|
in millions |
|
|
Derivative Assets |
|
|
|
Derivative Liabilities |
|
Exchange-traded |
|
|
$ 3,059 |
|
|
|
$ 2,666 |
|
|
|
OTC |
|
|
50,784 |
|
|
|
43,529 |
|
Total |
|
|
$53,843 |
|
|
|
$46,195 |
|
|
|
|
|
As of December 2013 |
|
in millions |
|
|
Derivative Assets |
|
|
|
Derivative Liabilities |
|
Exchange-traded |
|
|
$ 4,277 |
|
|
|
$ 6,366 |
|
|
|
OTC |
|
|
53,602 |
|
|
|
43,356 |
|
Total |
|
|
$57,879 |
|
|
|
$49,722 |
|
|
|
|
|
|
|
|
Goldman Sachs June 2014 Form 10-Q |
|
27 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
The table below presents the fair value and the notional amount of derivative contracts by
major product type on a gross basis. Gross fair values exclude the effects of both counterparty netting and collateral, and therefore are not representative of the firms exposure. The table below also presents the amounts of counterparty and
cash collateral netting in the condensed consolidated statements of financial condition, as well as cash and securities collateral posted and received under enforceable credit support
agreements that do not meet the criteria for netting under U.S. GAAP. Where the firm has received or posted collateral under credit support agreements, but has not yet determined such agreements
are enforceable, the related collateral has not been netted in the table below. Notional amounts, which represent the sum of gross long and short derivative contracts, provide an indication of the volume of the firms derivative activity and do
not represent anticipated losses.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of June 2014 |
|
|
|
|
As of December 2013 |
|
in millions |
|
|
Derivative Assets |
|
|
|
Derivative Liabilities |
|
|
|
Notional Amount |
|
|
|
|
|
Derivative Assets |
|
|
|
Derivative Liabilities |
|
|
|
Notional Amount |
|
Derivatives not accounted for as hedges |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rates |
|
|
$ 626,078 |
|
|
|
$ 573,843 |
|
|
|
$47,606,176 |
|
|
|
|
|
$ 641,186 |
|
|
|
$ 587,110 |
|
|
|
$44,110,483 |
|
|
|
Exchange-traded |
|
|
163 |
|
|
|
231 |
|
|
|
3,429,506 |
|
|
|
|
|
157 |
|
|
|
271 |
|
|
|
2,366,448 |
|
|
|
OTC-cleared |
|
|
232,572 |
|
|
|
216,279 |
|
|
|
28,501,398 |
|
|
|
|
|
266,230 |
|
|
|
252,596 |
|
|
|
24,888,301 |
|
|
|
Bilateral OTC |
|
|
393,343 |
|
|
|
357,333 |
|
|
|
15,675,272 |
|
|
|
|
|
374,799 |
|
|
|
334,243 |
|
|
|
16,855,734 |
|
|
|
Credit |
|
|
53,990 |
|
|
|
51,338 |
|
|
|
2,754,868 |
|
|
|
|
|
60,751 |
|
|
|
56,340 |
|
|
|
2,946,376 |
|
|
|
OTC-cleared |
|
|
5,433 |
|
|
|
5,332 |
|
|
|
381,086 |
|
|
|
|
|
3,943 |
|
|
|
4,482 |
|
|
|
348,848 |
|
|
|
Bilateral OTC |
|
|
48,557 |
|
|
|
46,006 |
|
|
|
2,373,782 |
|
|
|
|
|
56,808 |
|
|
|
51,858 |
|
|
|
2,597,528 |
|
|
|
Currencies |
|
|
59,009 |
|
|
|
51,532 |
|
|
|
5,123,746 |
|
|
|
|
|
70,757 |
|
|
|
63,659 |
|
|
|
4,311,971 |
|
|
|
Exchange-traded |
|
|
68 |
|
|
|
63 |
|
|
|
14,698 |
|
|
|
|
|
98 |
|
|
|
122 |
|
|
|
23,908 |
|
|
|
OTC-cleared |
|
|
116 |
|
|
|
125 |
|
|
|
13,404 |
|
|
|
|
|
88 |
|
|
|
97 |
|
|
|
11,319 |
|
|
|
Bilateral OTC |
|
|
58,825 |
|
|
|
51,344 |
|
|
|
5,095,644 |
|
|
|
|
|
70,571 |
|
|
|
63,440 |
|
|
|
4,276,744 |
|
|
|
Commodities |
|
|
17,711 |
|
|
|
17,515 |
|
|
|
719,827 |
|
|
|
|
|
18,007 |
|
|
|
18,228 |
|
|
|
701,101 |
|
|
|
Exchange-traded |
|
|
4,863 |
|
|
|
3,790 |
|
|
|
367,968 |
|
|
|
|
|
4,323 |
|
|
|
3,661 |
|
|
|
346,057 |
|
|
|
OTC-cleared |
|
|
266 |
|
|
|
298 |
|
|
|
3,267 |
|
|
|
|
|
11 |
|
|
|
12 |
|
|
|
135 |
|
|
|
Bilateral OTC |
|
|
12,582 |
|
|
|
13,427 |
|
|
|
348,592 |
|
|
|
|
|
13,673 |
|
|
|
14,555 |
|
|
|
354,909 |
|
|
|
Equities |
|
|
54,644 |
|
|
|
52,771 |
|
|
|
1,523,954 |
|
|
|
|
|
56,719 |
|
|
|
55,472 |
|
|
|
1,406,499 |
|
|
|
Exchange-traded |
|
|
9,963 |
|
|
|
10,580 |
|
|
|
551,650 |
|
|
|
|
|
10,544 |
|
|
|
13,157 |
|
|
|
534,840 |
|
|
|
OTC-cleared |
|
|
10 |
|
|
|
1 |
|
|
|
299 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bilateral OTC |
|
|
44,671 |
|
|
|
42,190 |
|
|
|
972,005 |
|
|
|
|
|
46,175 |
|
|
|
42,315 |
|
|
|
871,659 |
|
Subtotal |
|
|
811,432 |
|
|
|
746,999 |
|
|
|
57,728,571 |
|
|
|
|
|
847,420 |
|
|
|
780,809 |
|
|
|
53,476,430 |
|
Derivatives accounted for as hedges |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rates |
|
|
12,609 |
|
|
|
303 |
|
|
|
124,034 |
|
|
|
|
|
11,403 |
|
|
|
429 |
|
|
|
132,879 |
|
|
|
OTC-cleared |
|
|
4,056 |
|
|
|
26 |
|
|
|
38,365 |
|
|
|
|
|
1,327 |
|
|
|
27 |
|
|
|
10,637 |
|
|
|
Bilateral OTC |
|
|
8,553 |
|
|
|
277 |
|
|
|
85,669 |
|
|
|
|
|
10,076 |
|
|
|
402 |
|
|
|
122,242 |
|
|
|
Currencies |
|
|
16 |
|
|
|
116 |
|
|
|
9,684 |
|
|
|
|
|
74 |
|
|
|
56 |
|
|
|
9,296 |
|
|
|
OTC-cleared |
|
|
3 |
|
|
|
14 |
|
|
|
1,442 |
|
|
|
|
|
1 |
|
|
|
10 |
|
|
|
869 |
|
|
|
Bilateral OTC |
|
|
13 |
|
|
|
102 |
|
|
|
8,242 |
|
|
|
|
|
73 |
|
|
|
46 |
|
|
|
8,427 |
|
|
|
Commodities |
|
|
40 |
|
|
|
|
|
|
|
147 |
|
|
|
|
|
36 |
|
|
|
|
|
|
|
335 |
|
|
|
Exchange-traded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23 |
|
|
|
Bilateral OTC |
|
|
40 |
|
|
|
|
|
|
|
147 |
|
|
|
|
|
36 |
|
|
|
|
|
|
|
312 |
|
Subtotal |
|
|
12,665 |
|
|
|
419 |
|
|
|
133,865 |
|
|
|
|
|
11,513 |
|
|
|
485 |
|
|
|
142,510 |
|
Gross fair value/notional amount of derivatives |
|
|
$ 824,097 |
1 |
|
|
$ 747,418 |
1 |
|
|
$57,862,436 |
|
|
|
|
|
$ 858,933 |
1 |
|
|
$ 781,294 |
1 |
|
|
$53,618,940 |
|
Amounts that have been offset in the condensed consolidated statements of financial condition |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Counterparty netting |
|
|
(674,863 |
) |
|
|
(674,863 |
) |
|
|
|
|
|
|
|
|
(707,411 |
) |
|
|
(707,411 |
) |
|
|
|
|
|
|
Exchange-traded |
|
|
(11,998 |
) |
|
|
(11,998 |
) |
|
|
|
|
|
|
|
|
(10,845 |
) |
|
|
(10,845 |
) |
|
|
|
|
|
|
OTC-cleared |
|
|
(220,564 |
) |
|
|
(220,564 |
) |
|
|
|
|
|
|
|
|
(254,756 |
) |
|
|
(254,756 |
) |
|
|
|
|
|
|
Bilateral OTC |
|
|
(442,301 |
) |
|
|
(442,301 |
) |
|
|
|
|
|
|
|
|
(441,810 |
) |
|
|
(441,810 |
) |
|
|
|
|
|
|
Cash collateral netting |
|
|
(95,391 |
) |
|
|
(26,360 |
) |
|
|
|
|
|
|
|
|
(93,643 |
) |
|
|
(24,161 |
) |
|
|
|
|
|
|
OTC-cleared |
|
|
(21,460 |
) |
|
|
(1,428 |
) |
|
|
|
|
|
|
|
|
(16,353 |
) |
|
|
(2,515 |
) |
|
|
|
|
|
|
Bilateral OTC |
|
|
(73,931 |
) |
|
|
(24,932 |
) |
|
|
|
|
|
|
|
|
(77,290 |
) |
|
|
(21,646 |
) |
|
|
|
|
Fair value included in financial instruments owned/financial instruments sold, but not yet
purchased |
|
|
$ 53,843 |
|
|
|
$ 46,195 |
|
|
|
|
|
|
|
|
|
$ 57,879 |
|
|
|
$ 49,722 |
|
|
|
|
|
Amounts that have not been offset in the condensed consolidated statements of financial condition |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash collateral received/posted |
|
|
(692 |
) |
|
|
(2,166 |
) |
|
|
|
|
|
|
|
|
(636 |
) |
|
|
(2,806 |
) |
|
|
|
|
|
|
Securities collateral received/posted |
|
|
(10,951 |
) |
|
|
(10,331 |
) |
|
|
|
|
|
|
|
|
(13,225 |
) |
|
|
(10,521 |
) |
|
|
|
|
Total |
|
|
$ 42,200 |
|
|
|
$ 33,698 |
|
|
|
|
|
|
|
|
|
$ 44,018 |
|
|
|
$ 36,395 |
|
|
|
|
|
1. |
Includes derivative assets and derivative liabilities of $24.49 billion and $23.37 billion, respectively, as of June 2014, and derivative
assets and derivative liabilities of $23.18 billion and $23.46 billion, respectively, as of December 2013, which are not subject to an enforceable netting agreement or are subject to a netting agreement that the firm has not yet
determined to be enforceable. |
|
|
|
|
|
28 |
|
Goldman Sachs June 2014 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Valuation Techniques for Derivatives
The firms level 2 and level 3 derivatives are valued using derivative pricing models (e.g., discounted cash flow models, correlation models, and models that incorporate option pricing
methodologies, such as Monte Carlo simulations). Price transparency of derivatives can generally be characterized by product type.